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Zusammenfassung  
Hintergrund: 
Der am häufigsten benutzte Ergebniswert für die Bewertung der Behandlung cerebraler 
Aneurysmata ist der Glasgow Outcome Score (GOS). Dieser Score zeigt jedoch lediglich die 
Sicherheit der Behandlung an, wobei dessen Effizienz außer Acht gelassen wird. Ein 
unvollständig okkludiertes Aneurysma ist jedoch eine der Hauptursachen für eine 
verminderte Lebensqualität der Patienten (lebenslange Kontrolle oder erneute Behandlung, 
gesteigertes Blutungsrisiko). Daher schlagen wir ein neues Ergebnis-Scoring-System (BRS) 
vor, das auf dem konventionellen GOS basiert und nun zusätzlich den Grad der Okklusion 
des Aneurysma enthält. 
Zielsetzungen: 
1- Das Grundwissen über die zerebralen Aneurysmen mit einer kurzen 
zusammenfassendenden Betrachtung von Konfliktbereichen zu überprüfen um den 
aktuellen Forschungsstand bezüglich cerebraler Aneurysmen zu kennen um die 
zukünftigen Forschungstrends abzuleiten. 
2- Wissenschaftliche Evaluation durchzuführen, um einen dieser Konflikte zu lösen und 
um eine neue Skala zu entwickeln welche das Ergebnis der Behandlung cerebraler 
Aneurysmen bewertet. 
Material und Methoden: 
Wir haben unsere institutionelle Datenbank konsultiert und 532 Patienten (mit 622 
Aneurysmen) identifiziert, bei denen mindestens ein cerebrales Aneurysma mit Clip oder Coil 
behandelt wurde. Wir haben alle für die neue Beurteilung erforderlichen spezifischen Daten 
(BRS - kombinierter Score: GOS + Okklusionsgrad) extrahiert: die neurologische Leistung 
und den Grad der Okklusion des Aneurysma (basierend auf der postoperativen 
Rotationsangiographie (Okklusionsgrad: vollständig = A; kleiner Rest ≤ 3 mm = B; großer 
Rest> 3 mm = C)). 
Ergebnisse:  
• Bei innozenten Aneurysmen: 
GOS, Clipping Gruppe: 5=98.8% (n=166), 4=1.2% (n=2). GOS, Coiling Gruppe: 5=95.9% 
(n=139), 4=4.1% (n=6). BRS score, Clipping Gruppe: 5A=79.2% (n=133), 4A=1.2% (n=2), 
5B=15.5% (n=26), 5C=4.2% (n=7). BRS score, Coiling Gruppe: 5A=64.8% (n=94), 4A=0.7% 
(n=1), 5B=14.5% (n=21), 4B=2.1% (n=3), 5C=17.9% (n=26). 
• Bei rupturierten Aneurysmen: 
GOS, Clipping Gruppe: 5=61.5% (n=80), beeinträchtigtes Patientenergebnis=24.7% (n=32), 
Coiling Gruppe: 5=62% (n=111), beeinträchtigtes Patientenergebnis=17.3% (n=31). 
BRS score, Clipping Gruppe: 5A=56.2% (n=73), 5B=2.3% (n=3), 5C=3.1% (n=4). 4A=4.6% 
(n=6), 4B=0.8% (n=1), 3A=13.8% (n=18), 3B=0.8% (n=1), 2A (n=4.6%). 
Coiling Gruppe: 5A=33% (n=59), 5B=18.4% (n=33), 5C=10.6% (N=19), 4A=3.4% (n=6), 
4B=3.4% (n=6), 4C=1.1% (n=2), 3A=5% (n=9), 3B=3.4% (n=6 ), 2A=0.6% (n=1), 2C=0.6% 
(n=1) . 
Im Vergleich mit dem GOS hatte der BRS eine signifikant höhere Sensitivität und Spezifität, 
um die Effizienz der Behandlung vorherzusagen. Nach dem BRS erreichten signifikant mehr 
Patienten nach dem Clipping den höchsten Grad (5A) als nach dem Coiling (p <0,05). 
Fazit: 
Unsere neuen Scores (BRS- und Extended BRS), die die neurologische Leistung und die 
radiographisch bestätigte Okklusion kombinieren, sind einfach anzuwendende 
Graduierungen um das Ergebnis nach der Behandlung cerebraler Aneurysmata präzise 
vorherzusagen. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aims of the study: 
1- Review basic knowledge about the cerebral aneurysms, with brief telescopic 
view on areas of conflicts, to know the current state of research regarding the 
cerebral aneurysms to conclude what the future research trends should be. 
2- Conduct scientific research to solve one of these conflicts to evolve a new 
scale to evaluate the outcome of cerebral aneurysms treatments. 
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1. Introduction 
Cerebral aneurysms are focal dilatations of the intracranial arteries, which usually occur at 
their branching points. Most cerebral aneurysms remain asymptomatic and never rupture. 
When an IA ruptures, it may bleed into the brain parenchyma resulting in a parenchymal 
hemorrhage, or more often it will bleed into the subarachnoid space, resulting in a 
subarachnoid hemorrhage (SAH). (25) 
Aneurysms are not a disease unique to modern society. Both ancient literature and bony 
artifacts dating back to ancient Egypt indicate occurrences of aneurysms and at least some 
extracranial aneurysms were treated. Despite occasional reports, cerebral aneurysms were 
not well-recognized as a cause of human illness until the end of the 19th century. (19) 
Intracranial aneurysms are relatively common, with a prevalence of approximately 6%. 
There are four main types of intracranial aneurysms: saccular, fusiform, dissecting, and 
mycotic type. The saccular type accounts for 90% of intracranial aneurysms, 85% of which 
arises from the arteries of the anterior cerebral circulation. (24, 32) 
A SAH is a catastrophic medical event with a mortality rate of 25% to 50%. Permanent 
disability occurs in nearly 50% of the survivors, thus, only approximately one-third of patients 
who suffer from a SAH have a positive outcome. (25, 30, 43) The clinical manifestations of 
unruptured aneurysms are much more subtle, with the majority being identified incidentally 
during evaluation for other conditions. (38, 148) 
Symptoms related to unruptured aneurysms mainly occur due to a mass effect, but the real 
danger is when an aneurysm ruptures, leading to a subarachnoid hemorrhage. Although 
most cerebral aneurysms are asymptomatic and will not rupture, they grow unpredictably 
and even small aneurysms carry a risk of rupture. (111,112) 
There is a great conflict and controversy surrounding the natural history of unruptured 
aneurysms. It is such a hot topic because knowing the likely course of aneurysms will play a 
pivotal role in determining the appropriate management. Prior to 1998, the estimated rate of 
rupture for aneurysms was 1 to 2.5% per year. This value indicates that over many years, 
the risk of rupture is very significant, and therefore, surgical or endovascular treatment is 
appropriate in patients with incidental aneurysms (135). Treatment options include 
observation, endovascular coiling, and surgical clipping; microsurgical clipping has been 
used for the treatment of intracranial aneurysms for longer than 40 years and endovascular 
coiling devolped a lot in the past 20 years. Both neurosurgeon and neurointerventioists 
appreciate their methods of treating cerebral aneurysms, with all reports comparing both 
modality outcomes to be good. (75, 79, 86) 
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2. Review of literteur: 
2.1 Pathophysiology; 
2.1.1 Epidemiology; 
Studies have shown that IAs are common and the overall incidence ranges from 0.4% to 
10%, e.g. in the German population approximately 1.5–2 million people are assumed to 
harbour a cerebral aneurysms. Frequency increases with age beyond the third decade; 
incidence is rare in the pediatric population and is approximately 1.6 times more common in 
women. The risk of harbouring IAs is 2-4 times higher in families with two or more members 
with a history of IAs. Most IAs occurrences are sporadic and only less than 10% of patients 
have a family history of aneurysms. About one-third of all patients with IAs have multiple 
aneurysms. (72, 95) 
Although the incidence of IAs is comparable worldwide, their rupture rates are different. The 
incidence of aneurysmal SAH in most populations is 6–10 cases per 100,000 person/year; in 
united state about 30,000 people suffer a brain aneurysm rupture every year. In other words, 
there is a brain aneurysm rupturing every 18 minutes. The rupture rate increases in Finland, 
Japan and Northern Sweden, the incidence is 10–16 cases per 100,000 person/year. This 
higher incidence may be due to environmental or genetic factors, but reason still remains 
unknown. (116,122)  
2.1.2 Hypothesis for intracranial aneurysms formation: 
The majorities of intracranial aneurysms are not considered to be congenital as it has been 
assumed in the past, but it is generally accepted that IAs are acquired lesions, the actual 
mechanism of their formation is unknown. (115)The popular theory of a congenital defect in 
the tunica media of the muscle layer as a weak spot through which the inner layer of the 
arterial wall would bulge has had doubt cast upon it due to a number of contradictory 
observations: Gaps in the muscle layer are equally present in patients with and without 
aneurysms. If an aneurysm has formed, defect in the muscle layer is not located at the neck, 
but somewhere in the aneurysmal wall of the sac. (6,115) 
The most plausible pathogenetic theory is that they are acquired due to hemodynamic stress 
on the relatively unsupported bifurcations of cerebral arteries. This is supported by the 
clinical observation that many patients with an anterior communicating artery (Acom) 
aneurysm do have one hypoplastic or absent Al segment and thus an increased 
hemodynamic stress on the AcomA occurs. Other factors than hemodynamics and structural 
alterations of the vessel wall contributing to the development of saccular aneurysms may be 
genetic, infection, vascular trauma, neoplasms, radiation or idiopathic. (6, 83,120) 
The role of acquired changes in the arterial wall, in adults, is more likely to happen because 
there are general risk factors for both subarachnoid hemorrhage (SAH) and development of 
the aneurysms like hypertension, smoking and alcohol abuse. These factors might 
contribute to general thickening of the intimal layer in the arterial wall, distal and proximal to 
branching sites. These “intimal pads” are probably the earliest stages of aneurysm 
formation. Within these pads, the intimal layer is inelastic and therefore causes increased 
strain of the more elastic portions of the vessel wall. Abnormalities in structural proteins of 
the extracellular matrix additionally contribute to aneurysm formation. However, it is not 
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known why only some adults develop aneurysms at arterial bifurcations and most do not. 
(115,120,126,157) 
Inflammation has been found to have a principal role in the process of IA formation and 
subsequent rupture. Aspirin with its anti-inflammatory effects was found to be effective in 
decreasing the risk of aneurysm formation and subsequent SAH without increasing the risk 
of intracerebral hemorrhage. Aspirin might be a promising prophylactic drug against IA 
growth and rupture. (28,134) 
Many hereditary connective tissue diseases have been associated with formation of 
aneurysms, most likely as a result of the weakening of the vessel wall. Cerebral aneurysms 
may develop in 10%–15% of patients with polycystic kidney disease, an autosomal dominant 
disorder. Although Marfan syndrome was previously identified as a risk factor for aneurysms, 
recent studies do not identify any significant correlation. Coarctation of the aorta, 
fibromuscular dysplasia and pheochromocytoma are associated with intracranial aneurysms, 
most likely because of the elevated blood pressure that occurs under such conditions. There 
are some presumptions on neurofibromatosis type 1 (NFl) and intracranial aneurysms. In a 
recent study, an association between NFl and intracranial aneurysms has never been 
identified in large clinical studies and that there is no evidence for any association between 
NFl and intracranial aneurysms. (21, 96,117) 
Also, it is suggested that the formation of an intracranial aneurysm is a consequence of a 
systemic vascular pathology, which is associated with pleomorphism in different candidate 
genes. Understanding of the mechanisms behind the formation of IAs can provide an 
opportunity for the development of pharmacological therapy for IAs. (83,115,157)   
 
2.1.3 Genetics of intracranial aneurysms; 
Many genetic studies have aimed to determine if some genetic variants predispose 
individuals to the development of IAs. Multinational genome-wide association studies have 
defined five loci with strong statistical evidence and another 14 loci with suggestive evidence 
of an association with IAs. 5q26 is one suggestive risk locus for IAs which was also found to 
be associated with a risk of high systolic blood pressure. Besides, 9p21, which is a general 
cardiovascular risk locus, was found to be a strong risk locus for IAs. This overlapping 
genetic background suggests that the formation of IAs might be a part of generalized 
vasculopathy rather than a separate disease. (41,155) 
Prevalence of intracranial aneurysms among first-degree relatives of patients with cerebral 
aneurysms or a SAH is higher than in the general population, with the risk of harbouring an 
aneurysm is about three to four times higher than the general population. (115)  
Familial aneurysms are generally larger at time of rupture and more likely to be multiple than 
sporadic aneurysms. Cerebral aneurysms in patients with a positive family history might 
result from a mesenchymal defect affecting the cerebral vessel wall produced by a lesion of 
chromosome 16. (41) 
2.1.4 Histology of intracranial aneurysms: 
The wall of cerebral arteries is composed of three histologic layers: tunica intima, tunica 
media and tunica adventitia. The internal elastic lamina (IEL) separates the tunica intima and 
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tunica media. The wall of cerebral arteries differs from that of extracranial arteries in that it 
lacks the external elastic lamina (EEL) normally present in extracranial arteries between the 
tunica media and the tunica adventitia. Additionally, the cerebral arteries have a paucity of 
supportive perivascular tissues and fewer smooth muscle cells (SMC) in the tunica media 
and in IEL than extracranial arteries. Moreover, at the bifurcation of cerebral arteries which is 
the typical location for the formation of IAs, the tunica media consists mainly of collagen 
arranged in such a way that it increases resistance to mechanical stress. So the internal 
elastic lamina is an important layer of the arterial wall in the cerebral vessels. Thus, 
disruption of this layer due to alterations in hemodynamic and histological characteristics, 
would promote the formation of aneurysms especially at the regions around the bifurcations. 
In Helsinki, Frosen et al., four histological wall types for IAs are identified: type A, an 
endothelialized wall with linearly organized SMC; type B, a thickened wall with disorganized 
SMC; type C, a hypocellular wall; and type D, an extremely thin thrombosis- lined 
hypocellular wall. These types probably reflect consecutive stages (A through D) of 
degeneration suggesting a dynamic nature to the IA wall. (39, 75,134) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (1) Histology of the intracranial arteries depicting three layers of the intracranial wall (A and B) and the presence 
of medial gaps and pads of myointimal hyperplasia (C-E). F, drawing showing the relative locations of medial gaps and 
pads of myointimal hyperplasia at a vessel bifurcation.MCA, middle cerebral artery. (From Frosen J. The Pathobiology of 
Saccular Cerebral Artery Aneurysm Rupture and Repair: University of Helsinki; 2006). 
 
 
 
 
Figure (2) Saccular aneurysm, the thinning or the 
disappearance of the medial smooth muscle layer and 
the fragmentation or the absence of the internal 
elastic lamina are observed (elastica van Gieson 
stain, magnification ×100).   
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2.1.5 Morphology and classification of intracranial aneurysms: 
Classification of intracranial aneurysms can be based on morphology, size, location and 
etiology. Usually, intracranial aneurysms are divided into three basic types: saccular 
aneurysms when the protrusion is pouch-like or fusiform aneurysms when circumferential 
involvement of the parent artery occurs without a definite base or neck and dissecting 
aneurysms with unknown true prevalence. Traumatic, infectious or tumor-associated 
aneurysms are rare. (25, 26) 
2.1.5.1 Saccular aneurysms: 
Most cerebral aneurysms (66%–98%) are saccular and arise at arterial branching sites. 
They can arise as solitary (70%–75%) or multiple (25%–30%) vascular lesions. The majority 
of cerebral aneurysms (85%) are located in the anterior and only 15% are located in the 
posterior circulation. (25,156) 
Size: 
Saccular aneurysms may be divided into three, i.e. small, medium and large, four, five and 
even six groups. The most applicable is the five groups classification adapted by Yasargil: 
(153,154) 
1) Baby aneurysms (<2mm) (discovered during operative dissections)  
2) Small size (2- 6mm). 
3) Medium size (6-15 mm). 
4) Large size (15-25 mm). 
5) Giant aneurysms (25-60 mm). (7,154) 
Appearance: 
The neck of the saccular aneurysm may be small (1-3 mm) or large (4-10 mm) and well 
defined or not defined at all.(154) The variable Uni, bi or multilobular configurations with and 
without single or multiple thin or thick walled and even with well-defined secondary 
aneurysms are seen. Although small aneurysms are generally thought to have thin walls and 
the larger aneurysms increasingly thicker walls, it is not infrequently found unusual varieties. 
Usually the neck of an aneurysm has a thicker wall than the fundus and dome, but here 
again variations are also occurred. Each aneurysm appears to have its own "structural 
dynamics" or "natural history of development". (94,129) 
2.1.5.2 Aneurysms Associated with Arteriovenous Malformations: 
There is an increased incidence, or better, an increased amount of visible aneurysms 
associated with arteriovenous malformations. The incidence of these aneurysms in AVMs is 
up to 25%. Approximately 50% of these aneurysms are located on a feeding artery, 25% 
within the nidus. (14,123) 
Flow related aneurysms probably develop due to hemodynamic stress caused by increased 
flow and pressure, with subsequent dilatation and pathologic changes in feeding arteries. 
AVM-associated aneurysms contribute to an increased risk of hemorrhage. A 7% risk of 
hemorrhage for these combined lesions is estimated compared to a 1.7%–3% risk for AVMs 
without associated aneurysms. (90) 
In case of rupture, the hemorrhage is more often located intraparenchymally than 
subarachnoidally. Management of these combined lesions is still debatable. In fact, 
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hemodynamics change after elimination of the AVM might place the aneurysm at risk. On 
the other hand, proximal asymptomatic aneurysms may regress after removal of the AVM. 
However, aneurysms located in the posterior circulation associated with an AVM are at 
higher risk of rupture and therefore should be treated as soon as possible even if they had 
not ruptured before. (14, 90,130) 
 
 
Figure (3) Gross pathology specimen demonstrating saccular aneurysm (arrow), that arises at 
ICA- PComA Junction. Osborn et al., 1994 
 
Figure (4) Autopsy of unrecognized basilar bifurcation aneurysm 
in 2years child, Yasargil 1984 
 
 
                                         
 
                                                                               
 
          
2.1.6 Rupture of intracranial aneurysms: 
Most cerebral aneurysms remain clinically silent until they rupture. The International study of 
unruptured intracranial aneurysms (ISUIA) has been the most comprehensive clinical study 
of its kind to date, sseveral factors related to the patient and aneurysm-specific 
characteristics have been examined as possible predisposing factors for the rupture of IAs. 
In phase II of ISUIA, a higher rupture rate was reported to be associated with larger 
aneurysms, location in the posterior circulation, and previous history of SAH. (106) 
2.1.6.1 Patient-related risk factors: 
Prevalence of aneurysms and rupture risks were shown to increase in both studies due to 
the factors such as age of the patient; this risk increases accumulatively with age to peak 
between 40–65 years of age, pre-existing familial conditions, in patients with a family history 
of SAH, IAs rupture at a younger age. (33, 58) hypertension is the most frequently reported 
health condition associated with the formation of IAs and their subsequent rupture and was 
also found to be a risk factor for multiple IAs and for the rupture of small sized IAs. Smoking 
has been also associated with higher prevalence aneurysms and its rate of rupture. High 
alcohol consumption, cocaine use has been found to be significantly associated with 
aneurysmal SAH. (67,106) 
IAs are more commonly diagnosed in women than in men. Furthermore, aneurysmal SAH is 
more common in women. IAs, in women, carry a higher risk of rupture especially after 
menopause, which is probably related to the hormonal effects of estrogen on the vascular 
wall. (28, 50) 
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2.1.6.2 Aneurysm-related risk factor: 
Although aneurysm size has traditionally been considered a risk factor for the rupture of IAs, 
a single threshold value for an increased rupture risk has not been defined. Many studies 
have reported a significantly higher risk of rupture for saccular IAs larger than 10 mm 
compared to smaller aneurysms. The ISUIA reports that the rupture rate for aneurysms 
smaller than 7 mm was significantly lower than for those larger than 7 mm. However, in 
clinical experience, it is obvious that many small aneurysms do rupture and about 1/3 of all 
ruptured aneurysms were smaller than 7 mm in size. (102,148) 
Location of the aneurysms has been considered a risk factor for rupture, where posterior 
circulation aneurysms and aneurysms arising from the posterior communicating artery 
(PcomA) have a higher risk of rupture relative to anterior circulation aneurysms. Among 
anterior circulation aneurysms, Acom aneurysms have been reported to have the highest 
rupture rate, while MCA aneurysms had the lowest rupture rate. (13, 148) 
More recent studies focus on morphological characteristics of aneurysms to predict rupture 
risks. Several geometric indices, measured by using three-dimensional rotational 
angiography or digital subtraction angiography correlate with increased rupture rates. (119) 
The two highest indicators were the aspect ratio (the ratio of the aneurysm’s height to its 
neck) and the volume to neck ratio.(148) other noted two factors include presence of daughter 
sacs and the non-sphericity index, were strong predictors of aneurysm rupture as well. (102) 
2.1.6.3. Mechanism of rupture of intracranial aneurysms; 
It can be concluded that the growth potential of an individual aneurysm is unpredictable and 
as a result, no aneurysm regardless of size can be considered safe from enlargement and 
rupture over any period of time. IAs increase in size through real growth rather than 
stretching which attenuates the wall. Thus, aneurysm size might depict only the degree of 
wall growth, but not its strength. Wall morphology, on the other hand, correlates more 
strongly with the quality of wall growth and its resistance to rupture. (22,136) 
It is generally accepted that rupture occurs when the intra-aneurysmal hemodynamic stress 
surpasses its wall resistance. (67,119,148) other factors, such as complement activation and 
protein kinases are involved in IA growth and rupture. Although several hypotheses have 
been postulated to explain this association, the underlying mechanism is still unproven. 
Histological, genetic, immunological and molecular biologic studies are still needed to 
explain the relationship between the morphological characteristics of IAs and their rupture. 
Besides, large-scale clinical studies are needed to evaluate the predictive value of other 
morphological variables related to the risk of rupture. (87) 
 
2.1.7 Spontaneous Thrombosis of Cerebral Aneurysms: 
Although not frequently, various degrees of thrombosis may occur within aneurysms of any 
size, but thrombosis within larger lesions is more common. The histopathological series 
clearly demonstrate that thrombus formation on luminal surface of the aneurysm wall is part 
of the wall degeneration with the first degenerative change is the loss of intact endothelial 
layer, which leads to the formation of the fibrin network and thrombus on the exposed 
collagen surface. Thrombosis within an aneurysm is important with regard to both the 
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increased difficulty of management and the possible treatment of aneurysms without 
intracranial procedures by the initiation of thrombosis within the lesion. Luminal thrombus 
formation induction in the aneurysm fundus can prevent later rupture if the thrombus 
becomes stable and organized into fibrous tissue. However, up to 20% of embolized 
aneurysms, recanalization occurs on follow up, and may regrow and rupture due to 
thrombus organization failure. (34,154) 
There is no evidence that an aneurysm found at angiography or computerized tomography 
to contain some thrombus will go on to complete thrombosis and the degree of protection 
against rupture or rerupture afforded by thrombosis unfortunately, cannot at present be 
stated with certainty.  (34,154) 
 
 
 
 
Figure (5) Intraventricular hemorrhage and death was caused by 
the rupture of this almost completely thrombosed right internal 
carotid bifurcation aneurysm in a 48 year old man, yasargil 1984 
 
 
 
 
 
2.2 Clinical Presentation: 
The clinical presentation of an intracranial aneurysms depends on several factors, mainly 
the location of the aneurysm, its size, whether it ruptures or not and if it does, the amount of 
bleeding resulting from its rupture, the site of bleeding, the presence or absence of 
additional complications.(76, 92) Accordingly, patients with cerebral aneurysms may 
experience the following: 
1) Warning premonitory signs and symptoms 
2) Rupture of the aneurysms.  
3) Unruptured symptomatic aneurysm. 
4) Unruptured asymptomatic aneurysms. (87) 
2.2.1 Aneurysmal SAH: 
Most intracranial aneurysms remain silent till the time of rupture. SAH, a medical neurologic 
emergency, is by far the most common initial clinical presentation. A history of abrupt onset 
of a severe headache of atypical quality (“the worst headache in my life”) is typical of SAH. 
Headache onset may or may not be associated with brief loss of consciousness, nausea and 
vomiting, focal neurologic deficits or meningism.(76,98,146) the rupture of an IA is the main 
cause of nontraumatic SAH, accounting for around 80% of all cases, and responsible for 2–
5% of all new strokes. The mean age at presentation is 55 years with an increasing 
incidence with age. Women are at a 1.6 times higher risk of experiencing aneurysmal SAH 
than men. (37,139) 
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There may be a small number of SAH that functions as a “warning leak” or sentinel 
hemorrhage, usually associated with milder symptoms, which is only a sudden severe 
headache. In general, there is a correlation between the extent of SAH and the clinical 
grade, incidence of vasospasm, and other complications such as cerebral ischemia, 
increased intracranial pressure, and hydrocephalus. With increased severity of SAH there 
are increasing changes in physiologic parameters such as reduced cerebral blood flow (due 
to reduced cerebral autoregulation), hypovolemia, hyponatremia, hypermetabolism and 
cardiac arrhythmia. Stopping of a SAH is caused by a combination of tamponade due to 
reduced transmural pressure gradient across the arterial wall and coagulation. (59, 76, 92,136) 
2.2.1.1 Rebleeding after SAH: 
Rebleeding is a frequent and sometimes devastating neurologic complication of SAH which 
clinically coexist with new neurologic deficits, increasing headache, vomiting and a 
decreased level of consciousness. It is postulated to be due to breakdown of perianeurysmal 
clots as clot formation and tissue damage stimulate fibrinolytic activity in the CSF. The 
efficacy of antifibrinolytic therapy such as aminocaproic acid and tranexamic acid to prevent 
rebleeding showed a significantly decreased incidence of rebleeding, however, mortality was 
not altered, but this therapeutic approach was associated with an increased risk of delayed 
cerebral ischemia, embolism, and deep venous thrombosis. (86,114) 
The peak incidence of rebleeding is during the first day, a secondary peak occurs a week 
after SAH. Early rebleeding in the first hours after admission for the initial hemorrhage with 
clinical deterioration occurs in up to 18% of patients. (40) Since these early rebleedings 
commonly occur before the first CT scan is obtained, the true frequency of early rebleeding 
is definitely underestimated. As many as 20% of patients may rebleed within the first 2 
weeks, one third in the first month, and 50% will rebleed within 6 months, if the aneurysm is 
not treated and the mortality of recurrent SAH is 50%. (86,143,156) 
Women have a 2.2 times higher recurrence rate of hemorrhage than men. The worse the 
clinical grade on admission, the more likely rebleeding occurs. Hypertension increased the 
likelihood of rebleeding among patients. Of patients with a diastolic blood pressure below 90 
mm Hg, 25% rebleed, whereas of those with a diastolic pressure above 109, 75% rebleed. 
Older patients are more prone to rebleeding. Aneurysms pointing down are less likely to 
rebleed than those pointing up in the direction of the jet stream of the blood. Short broad 
aneurysms rebleed more frequently than long narrow aneurysms. Posterior communicating 
artery aneurysms rebleed at a higher rate than do anterior communicating artery and 
vertebrobasilar aneurysms. (114,132) 
2.2.1.2 Vasospasm related to SAH: 
Vasospasm is a major cause of morbidity and mortality in patients after SAH and is often 
associated with delayed cerebral ischemia. However, many patients are asymptomatic 
despite various degrees of angiographically visible vasospasms. Although vasospasm is 
noted angiographically in 70% of patients after SAH, it becomes symptomatic only in about 
half of those patients. This difference probably suggests additional factors determining 
whether and where secondary cerebral ischemia occurs like the degree of arterial narrowing, 
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its location and the adequacy of collateral blood flow, as well as other factors such as in-
creased intracranial pressure or the presence of cerebral oedema. (69) 
Unlike rebleeding, the clinical presentation of vasospasm develops slowly over hours up to 
days. The onset being rare before the third post-ictal day, with a peak incidence at about the 
seventh day, between day 4 and 12, it rarely persists for longer than 3 weeks after SAH. (49, 
78) 
Vasospasm is best detected on angiograms. However, transcranial Doppler ultrasound is 
the method of choice to monitor blood flow velocities in patients after SAH. CTA and MRA 
role has not been determined in this subgroup of patients. A CT perfusion is feasible in 
detecting vasospasm and might even predict outcome. (55, 56) 
Despite intensive research, the pathogenesis of vasospasm has not been entirely 
elucidated. Releases of yet unidentified factors into the subarachnoid space are considered 
to induce vasospasm and subsequent cerebral ischemia. There is a widespread postulation 
of a close relationship between the amount of subarachnoid blood clots and the degree of 
vasospasm and delayed cerebral ischemia. However, there are several arguments against 
these assumptions; subarachnoid blood is not a predictor of vasospasm perse, since 
vasospasm and delayed cerebral ischemia rarely occur in patients with SAH after rupture of 
an AVM or perimesencephalic SAH, one would expect a lower incidence of vasospasm after 
clipping compared to coiling, since there is no way to remove a subarachnoidal clot during 
coiling. But this effect has not been observed. Furthermore, the site of delayed cerebral 
ischemia does not always correspond with the distribution of subarachnoid blood. (55, 57) 
 
2.2.2 Interparynchymal Hematoma: 
Intracerebral hematoma (ICH) occurs in up to 30% of patients with aneurysmal rupture. The 
outcomes for those patients were found to be worse than SAH alone. It was reported in one 
cooperative study that ICH was present in 90% of patients who died within 72 hours of the 
aneurysmal SAH ictus. Acute subdural hematoma (SDH) is usually associated with recurrent 
aneurysmal rupture. However, SDH can also occur with the initial SAH or can be the only 
extravascular space involved after aneurysmal rupture. (128,140) 
 
2.2.3 Unruptured Aneurysms: 
Asymptomatic aneurysms may be defined as additional aneurysms found in patients with 
another symptomatic aneurysm, which are not responsible for the clinical symptoms or those 
aneurysms found in patients investigated because they are at risk of harbouring an 
aneurysm and those found unexpectedly in patients undergoing investigation for any other 
suspected pathology or unrelated clinical symptoms. (74) 
Depending on the location of an unruptured aneurysm it can be completely asymptomatic. 
On the other hand, unruptured aneurysms can cause neurologic symptoms while touching or 
transmitting pulsation to cranial nerves or other cerebral structures. Symptoms can be pain, 
cranial nerve palsies, visual disturbances, dysesthesia, vertigo and seizures. 
Thromboembolism ischemic events can occur distal to both small and large unruptured 
intracranial aneurysms (predominantly in the anterior circulation) were observed in 3.3%. (101) 
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Symptomatic unruptured aneurysms are usually larger than incidental aneurysms and are 
often discovered near to the skull base where they are more likely to affect cranial nerves. 
The most frequent affected cranial nerves are the ocuoculomotor nerve and the optic nerve. 
(74,100) 
Given the high mortality and morbidity associated with an aneurysm rupture, it is crucial to 
determine the likelihood of rupture to decide whether to treat an aneurysm or not. The 
findings of the ISUA have a lot of criticism and failed to solve these issues. (74,148) 
 
2.3 Diagnostic Studies of intracranial aneurysms: 
Cerebral angiography was introduced in 1927 (Moniz), and has been the mainstay of 
diagnosis in cerebral aneurysms ever since. In the past, the purpose of angiography has 
been two folds: to define the aneurysm and the anatomical and physiological state of the 
blood vessels associated with it, and to detect hematoma, hydrocephalus and brain shifts 
associated with rupture of the aneurysm. (2, 53, 80) with the coming of computerized 
tomography, there has necessarily been a change in the application of angiography to 
patients with ruptured cerebral aneurysm. While angiography remains the most accurate 
method of delineating an aneurysm, determining the presence of multiple aneurysms, and of 
assessing the cerebral circulation, CT has proved more useful in defining the real size of an 
aneurysm in determining the degree of thrombosis, and in evaluating associated 
hydrocephalus, infarction, and intracerebral hematomas. (2, 153, 154) 
2.3.1 Computed Tomography. 
Currently, the diagnosis of intracranial aneurysms on the CT scan is only approximate, as 
only angiography gives in most of the cases a clear picture. However, the CT diagnosis of 
aneurysms down to 6 mm in size has been possible and also Thrombus within an aneurysm 
is usually well shown by CT. (2, 53) 
By good discrimination between relatively similar densities within the cranial vault, CT is the 
initial diagnostic imaging modality of choice and clearly the gold standard to identify, localize 
and quantify subarachnoid hemorrhage and to portray many of the pathogenetic sequelae of 
ruptured cerebral aneurysm i.e. hydrocephalous, ischemia. (80,154) 
CT sensitivity for detecting SAH depends on the volume of the extravasated blood, the 
hematocrit, and the time elapsed after the acute event. With modern CT scanners, within the 
24 h after the ictus CT detects SAH in up to 95%. However, due to dilution by CSF the 
density of the hemorrhage decreases rapidly over time, thus after only a few days it may be 
impossible to demonstrate subarachnoid blood on CT. (102) Sensitivity of CT decreases to 
80% at day 3, to 70% at day 5, to 50% at 1 week, and to 30% at 2 weeks. (109) 
The pattern of SAH can suggest the location of the underlying aneurysm i.e. sylvian SAH 
suggest MCA aneurysms, interhemispheric for Acom. (62,154) and in cases of multiple 
aneurysms the presence of localized hematoma or infarction may suggest which of the 
lesions has bled. (154)  
Fisher et al. (1980) provided a description for a correlation between the amount and 
distribution of subarachnoid blood after aneurysmal rupture on the initial CT, with 
subsequent occurrence of vasospasm demonstrated by angiography. Since then, the CT-
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based Fisher classification of quantifying local amounts of subarachnoid blood as a powerful 
predictor for the occurrence of vasospasms and delayed cerebral ischemia has been 
confirmed by several clinical and experimental studies.(89, 124) However, the predictive value 
of the Fisher grading system is not perfect. Never assume that a patient will not develop 
vasospasm just because he has a low Fisher score. (82) 
Score Description 
0 Unruptured. 
1 No blood detected. 
2 Diffuse or vertical layers <1 mm thick. 
3 Localized clot and/or vertical layer >1 mm thick. 
4 Intracerebral or intraventricular clot with diffuse or no subarachnoid haemorrhage. 
                              Table (1) Fischer grading score, Mayfrank 2001 
 
 
 
 
Figure (6) Plain axial CT brain; RT 
SAH, LT MCA Intracerebral 
hemorrhage.Elshargawy2014 
 
 
 
 
 
2.3.2 CT Angiography (3D CTA):    
Angiography via CT scanning has a potentially important role in the acute investigation of 
spontaneous SAH. Such a tool is particularly attractive even to the endovascular therapist 
since once the cause of aneurysmal SAH has been identified, treatment can be planned and 
DSA performed under general anaesthesia, immediately prior to embolization. As a tool to 
identify patients with unruptured aneurysms among those with thunderclap headache, an 
accurate noninvasive vascular imaging technique would be of considerable interest. (80) 
Sensitivity of single-slice CT angiography in the investigation of intracranial aneurysms has 
been reported after the improvement of image quality and spatial resolution. Wintermark et 
al. (2003) concludes that sensitivity, specificity and accuracy values of multi-row CTA of 
99%, 95.2% and 98.3%, respectively. (144) Nevertheless, this technique has demonstrated a 
limited sensitivity for aneurysms smaller than 3 mm (25%–64%). Multi-row CT technology 
will make life clearly easier at emergency departments; patients with a first-time headache 
and a negative unenhanced CT scan will get a quick and reliable CTA, to optimize treatment 
planning and work-flow CTA may also be used to stratify patients into endovascular and 
surgical treatment groups. (45,144) 
CTA requires an iodine contrast agent and is associated with radiation exposure, which is a 
significant drawback in using CTA for community screening, particularly if this needs to be 
performed several times during an individual patient’s lifetime. However, CTA clearly plays a 
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role in the pre-therapeutic phase in large, giant, partially calcified and thrombosed 
aneurysms, as it visualize the exact anatomy of the neck, the relationship to adjacent bony 
structures and to determine the best treatment modality. (45,151) 
CTA is more likely to be useful in patients after aneurysm clipping, as there are 
reconstruction algorithms available that allow for the reduction of clip-related artifacts to a 
minimum and thus enables decision-making whether the aneurysm is completely clipped or 
not. (45,151) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (7) CTA images (A: axial, B: coronal, C: sagittal and the corresponding 3D reconstruction views (D, E and F, 
respectively) illustrating MCA aneurysm (white arrows) arising at the origin of a large early frontal cortical branch (green 
arrow) just proximal to the right MCA genu.Elshargawy2014. 
 
2.3.3 Magnetic Resonance Imaging (MRI): 
Magnetic resonance imaging and MRA are increasingly used in the diagnostic work-up of 
patients with cerebral aneurysms. However, MRI is less suitable than CT in patients with 
acute SAH because they are often restless and need extensive monitoring. (118) Subtle 
amounts of subarachnoid blood can be detected by MRI when using FLAIR or proton-
density weighted MR sequences, even before it can be detected by CT. (118,149) MRI is also 
superior to CT in demonstrating SAH in patients presenting late after aneurysm rupture and 
may be positive for SAH when CT is normal. (118) 
MRI is more useful in detection of other causes of subarachnoid haemorrhage in patients 
with a negative angiogram, such as a thrombosed aneurysm or spinal vascular malformation 
and it will increasingly be used in screening programs and as a follow-up tool after 
endovascular therapy. Diffusion weighted MR imaging is a potentially useful tool for 
monitoring patients after endovascular treatment, in order to permit early detection of 
ischemic complications, as it is more sensitive than CT leading to their early treatment. 
(118,149) 
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Figure (8) Axial T2 MRI brain scan,  showing a partially thrombosed giant 
MCA aneurysm on the RT side. Osborn2003 
 
 
 
 
2.3.4 Magnetic Resonance Angiography: 
MR angiography provides a fast, accurate and non-invasive evaluation of intracranial 
aneurysms without the risk of conventional angiography; however, MRA has not yet 
replaced catheter angiography. (2, 12) Aneurysm size is a crucial factor for sensitivity. MRA 
studies consistently indicate sensitivity rates of more than 95% for aneurysms larger than 6 
mm, but much less for aneurysms smaller than 5 mm, which constitute as many as a third of 
aneurysms in asymptomatic patients, detection rates of 56% and less have been reported. 
(2,113) 
Present indications for MRA in the evaluation of cerebral aneurysms in general include: 
Incidental findings on CT or MRI suspicious for an aneurysm. Evaluation of specific clinical 
symptoms (i.e. third cranial nerve palsy) or non-specific symptoms in whom an aneurysm 
might explain the clinical presentation, screening in “high risk” patients (first-degree relatives 
of patients with SAH, multiple aneurysms, polycystic kidney or connective tissue diseases). 
(12) 
 
Figure (9) (a) Time of  flight MR angiography of normal intracranial vessels(b) Contrast-enhanced MRA technique with a 
large field-of-view covering all vessels from the aortic arch to the circle of Willis(c) small A COMM aneurysm. Atlas of 
neurovascular anatomy and pathology2007. 
2.3.5 Intra-arterial Digital subtiaction Augiography (IA-DSA): 
Owing to its excellent spatial resolution, conventional cerebral angiography is still the gold 
standard for detecting a cerebral aneurysm. Currently, this is performed during the first 
available moment after presentation of the patient at the hospital after SAH, as the risk of 
rehemorrhage is highest in the first 24h. (8)  Compared to the non-invasive methods (CTA 
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and MRA), DSA is the gold stander method to evaluate all components of the circle of Willis, 
identify the aneurysm site, anatomical assessment of its vascular geometry (in particular 
delineating the size, shape, number of lobules, direction of fundus projection, presence of 
irregularities or loculations in the aneurysm wall, and relationship of the aneurysm neck to 
the parent arteries and adjacent arteries, distinguish aneurysm from vascular loops and 
infundibula and appreciate the cross filling from one side to the other and from the 
vertebrobasilar circulation and elongation, tortuosity, and atherosclerotic narrowing of 
cerebral vessels.(35,154) It is also helpful in screening for aneurysms, to follow the status of 
untreated or partially treated aneurysms, to ensure proper aneurysm obliteration 
postoperatively, and to sequentially evaluate the status of vasospasm. (8, 35, 97) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure (10) RT internal carotid artery angiography. The normal carotid circulation; 1 internal carotid artery – cervical 
segment   2 internal carotid artery – vertical petrous segment   3 internal carotid artery – horizontal petrous segment   4 
presellar (Fischer C5) segment internal carotid artery    6 horizontal (Fischer C4) intracavernous internal carotid artery   
9 ophthalmic artery    10 & 11 proximal and distal supraclinoid segment internal carotid artery     12 posterior 
communicating artery   13 anterior choroidal artery    14 internal carotid artery bifurcation  15 A1 segment of anterior 
cerebral artery 17 recurrent artery of Heubner    20 proximal A2 segment anterior cerebral artery  21 callosomarginal 
branch of anterior cerebral artery    28 pericallosal branch of anterior cerebral artery    31 M1 segment of middle cerebral 
artery    32 lateral lenticulostriate arteries    33 bifurcation/trifurcation of middle cerebral artery  34 anterior temporal 
lobe branches of middle cerebral artery  35 orbitofrontal branch of middle cerebral artery  43 sylvian point   44 opercular 
branches of middle cerebral artery  45 sylvian (insular) branches of middle cerebral artery,3D Angiography atlas of 
neurovascular anatomy and pathology2007. 
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Figure (11) Vertebrobasilar angiography, frontal & lateral , The normal intracranial vertebral basilar circulation.1 
vertebral artery 2 posterior inferior cerebellar artery (PICA) 2v vermian branch of PICA 2h hemispheric branch of PICA 3 
basilar artery 4 anterior inferior cerebellar artery (AICA) 5 superior cerebellar artery (SCA) 5h hemispheric branch of 
SCA 6 posterior cerebral artery (PCA) 6.2 P2 segment of posterior cerebral artery 7 posterior communicating artery 8 
posterior temporal branch of PCA 9 parieto-occipital branch of PCA 10 calcarine branch of PCA 11 anterior 
thalamoperforators 12 posterior thalamoperforators 13m medial posterior choroidal arteries 13L lateral posterior 
choroidal arteries 14 vertebral-basilar junction 15 splenial branch (posterior pericallosal artery) of PCA 17 anterior 
spinal artery ** region of quadrigeminal plate cistern, 3D Angiography atlas of neurovascular anatomy and 
pathology2007. 
 
2.3.6 Plain Skull Radiography: 
Although not used nowadays, it is reported that, small intracranial aneurysms cause no 
abnormalities on plain radiography of the skull but large aneurysms may show erosion of the 
base of the skull, particularly in the sphenoid bone and sella turcica, or the lesion itself may 
be partially calcified. (154) 
 
 
 
 
Figure (12) lat view plain X ray the calcified wall of the aneurysm is outlined 
(arrow heads), Yasargil V2 1984. 
 
2.3.7 Transcranial Ultrasound: 
 Although the technique is quick, safe, inexpensive and non-invasive, it is highly dependent 
on the skills of the operator. At the moment, TCD for the detection of cerebral aneurysms is 
only of scientific interest and cannot be recommended for routine use. In fact, it does not 
play any role in diagnostic work-up of SAH patients or in screening. (46,147) TCD is used to 
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study changes in cerebral arterial flow velocity after subarachnoid hemorrhage and after 
surgery of cerebral aneurysms. A steep early increase in flow velocity seems to predict 
future ischemia. Velocities over 200 cm per second almost always occur in patients with 
severe vasospasm. Flow velocitie is only a rough guide to vasospasm and must take in 
account the clinical conditions and available radiological imaging. (147) 
2.3.8 Electroencephalography (EEG): 
While EEG has little use in the diagnosis and localization of ruptured cerebral aneurysm, it 
nevertheless finds some application in the evaluation of brain function in patients who are 
obtunded or comatose following subarachnoid hemorrhage. (154) 
Van der Drift (1961) summarized the findings on EEG in patients with ruptured cerebral 
aneurysm and noted that EEG findings basically paralleled the disturbances in cerebral 
blood flow, but noted that the EEG tracing tended to normalize within 6 weeks of 
hemorrhage while blood flow alterations could persist. (138) 
In an interesting recent case, in the author's series, a 45-year-old woman presented with 
subarachnoid hemorrhage and angiography revealed bilateral MCA aneurysms. 
Computerized tomography was not helpful in determining which of the lesions had bled. An 
EEG, however, showed dysfunction on the left cerebral hemisphere. Because the right-sided 
aneurysm was significantly larger than the left, operation was carried out on the right side 
and an unruptured aneurysm was found. Subsequent left sided exploration revealed the 
aneurysm which had bled. In this case EEG proved more helpful than angiography for 
localization of hemorrhage. (62) Techniques such as this might find application in the 
prognosis of comatose patients and in determining case selection for operation. (138,154) 
2.3.9 Positron Emission Tomography: 
Positron Emission Tomography or PET scanning is an in vivo autoradiographic technique for 
measuring cerebral blood flow and metabolism. A variety of radioactive short half-life 
materials are injected intra-arterial necessitating the immediate availability of a cyclotron. 
This drastically limits the widespread use of PET scanning, currently confined to research 
purposes. With its ability to quantitate cerebral blood flow and metabolism, PET scanning is 
being applied to aneurysm patients with associated vasospasm. Efforts are underway to 
demonstrate that symptomatic patients with vasospasm have an uncoupling of cerebral 
blood flow and metabolism. Future work with this new investigative device will certainly shed 
light on the pathophysiology of subarachnoid hemorrhage induced vasospasm. (80,147,154) 
2.3.10 Nuclear Magnetic Resonance: 
Nuclear Magnetic Resonance or NMR scanning allows a tomographic picture of tissue 
based on its electron density. At present, the application of imaging and metabolic NMR to 
cerebral aneurysms awaits further development. (46, 80,147) 
 
2.4 Treatment of intracranial aneurysms: 
2.4.1 Management of aneurysmal SAH: 
In addition to the prevention of rebleeding, the main goal of treatment for patients with 
ruptured IAs is to manage the complications associated with SAH, in particular, vasospasm. 
For vasospasm prophylaxis, oral Nimodipine is traditionally administered and prescribed to 
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patients for three weeks once aneurysmal SAH is diagnosed. Nimpodipine was associated 
with a 40% reduction in poor outcomes after an aneurysmal SAH. Other drugs, such as 
magnesium sulphate and statins, are occasionally used, but with fewer reported benefits. 
The use of triple-H therapy (hypervolemia, hemodilution and hypertension) is more 
controversial and is usually reserved for symptomatic patients. Endovascular mechanical 
and/or pharmacological angioplasty is increasingly being used to treat cerebral vasospasms. 
(23, 29, 31, 44, 152) 
2.4.1.1 Anesthetic consideration for aneurysmal SAH:   
Hypertension, which may be the precipitating event that leads to the rupture of the 
aneurysm, is often a long-standing issue for patients with SAH. Thus, blood pressure control 
may be relative to a patient's baseline blood pressure. To avoid lowering blood pressure 
excessively, cerebral perfusion pressure (CPP) must be maintained at adequate levels. The 
American Heart Association (AHA) 2012 Guidelines for the management of aneurysmal SAH 
do not give any specific blood pressure recommendation. However, general 
recommendations call for systolic blood pressure <160 mmHg because of the risk of 
rebleeding. (29, 84) 
Nimodipine is recommended by AHA for all patients with SAH for vasospasm prophylaxis. 
Although it has not been shown to improve cerebral vasospasm by angiogram, Nimodipine 
has decreased delayed ischemia and improved neurologic outcomes. Verapamil has been 
shown to improve neurologic outcomes without increasing ICP. Erythropoietin has shown 
some promise in lowering the incidence of vasospasm and DCI, it also has shown improved 
outcomes, but further studies are needed to confirm this result. (133,141) 
Up to 26% of patients with SAH experience seizure-like episodes. Some small, 
nonrandomized studies have shown that prophylactic use of anticonvulsant therapy in the 
immediate posthemorrhage period may be beneficial, but definitive research suggests its 
efficacy is lacking. If such therapy is used, only a short course (3-7days) is 
recommended. (62,108) 
Anemia is common in SAH patients. The average drop in hemoglobin concentration in SAH 
patients is 3 g/dL. Higher hemoglobin levels have been associated with positive functional 
outcome. Blood transfusions, however, carry associated risks, such as an impaired immune 
system and increased incidence of infection. The Neurocritical Care Society recommends 
maintaining hemoglobin between 8-10 g/dL and maintaining higher levels (up to 12 g/dL) for 
patients at risk for DCI. (9,108, 127) 
When aneurysm obliteration is delayed, antifibrinolytic drugs such as aminocaproic acid or 
tranexamic acid have been shown to reduce the incidence of rebleeding, although neither of 
these drugs is approved by the United States FDA for this use. (29,86,90) Data suggest that 
treatment with statins may help reduce the size and growth progression of cerebral 
aneurysms, but more investigation is necessary to determine dosing, as conflicting data 
show that statins may increase aneurysm size at higher doses. (9, 54) 
2.4.1.2 Time of Aneurysm Treatment after Subarachnoid Hemorrhage: 
Over many years, the most suitable timing of ruptured aneurysm surgery has been 
debatable. In the 1960s and 1970s, most patients were operated on in the late phase 2 or 3 
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weeks after the hemorrhage as surgery in the initial 2 weeks was considered too dangerous, 
because operating on swollen and vulnerable brain tissues led to high rates of perioperative 
complications. This was particularly true during the period of maximum vasospasm between 
days 4 and 10 which was considered a particularly dangerous period to operate, because of 
the risk of delayed cerebral ischemia (DCI). Extensive evidence is available demonstrating 
that early surgery within 72 hours after the onset of SAH is associated with improved 
outcome among patients with ruptured cerebral aneurysms in the anterior circulation. The 
ideal timing of surgery for cerebral aneurysms in the posterior circulation is still controversial. 
A Cohrane review in 2001 identifies only 1 randomized clinical trial on timing of surgery after 
aneurysmal SAH. In this trial, patients undergoing early surgeries (days 0–3) tended to have 
the best outcome, and patients undergoing intermediate surgeries (days 4–7) the worst. A 
systematic review that included not only this trial, but also 10 observational studies in 2012, 
concludes that both early (days 0–3) and intermediate (days 4–7) surgical treatments 
resulted in better outcomes than did late surgery. In conclusion, it is evident that aneurysm 
treatment after day 10 is associated with worse outcome, regardless of treatment modality 
and advocates treatment of the aneurysm as early as possible after SAH. (159) 
Interestingly, microsurgical clipping between days 5 to 10 did not lead to a higher chance of 
DCI, whereas coiling between days 5 to 10 did increase the chance of DCI, but not poor 
outcome. Based on these results, it is not recommend to postpone clipping until day 10 or 
later in patients who are candidates for aneurysm treatment earlier. (159) 
 
2.4.2 Management of ruptured IAs with ICH: 
There is still some controversy regarding the adequate management of patients with a 
massive ICH caused by the rupture of an IA. It has been reported that the surgical 
evacuation of ICH without the clipping of the ruptured IA was associated with a 75% 
mortality rate, while combining aneurysm obliteration with ICH evacuation resulted in a 29% 
mortality rate. While some advocate for the coiling of the ruptured aneurysm first and, then, 
evacuating the ICH, the combination of endovascular and surgical treatments would expose 
the patient to the risks associated with both treatment modalities. Early surgical removal of 
massive ICH is believed to improve the outcome of ruptured aneurysms and avoid time 
delays with an increased intracranial pressure. (1, 93,129) 
 
2.4.3 Treatment of Unruptured cerebral Aneurysms: 
This is still a controversial topic and no solid indications up till now have been in agreement 
about. The management of asymptomatic unruptured aneurysms remains controversial and 
depends on a full understanding of their natural history balanced against the risks of 
treatment and long-term protection afforded. (65,148) unfortunately, unruptured aneurysms are 
a heterogeneous entity, both in terms of morphology and behaviour, e.g. tendency to 
rupture. Aneurysm size, certain locations with an increased risk of rupture perse: posterior 
circulation aneurysms and those aneurysms arising from the pcomm, hypertension, 
aneurysm multiplicity, multilobular aneurysm, female sex, heavy alcohol consumption, 
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smoking, and ruptured aneurysm in another location being specific risk factors for a higher 
probability of rupture and therefore treatment is indicated. (65, 142, 146) 
Surgical and endovascular treatment of unruptured aneurysms demonstrated that the costs 
treating an unruptured aneurysm are significantly lower than treating patients with SAH 
regarding length of hospital stay and sequelae of morbidity and mortality. (65) 
Currently, healthcare is undergoing a major reorganization to meet growing economic 
pressure and the aspect of preventive therapy becomes more and more important. 
Therefore, indication for treatment of an unruptured aneurysm has to be considered in 
several respects: what is the risk of aneurysm rupture and what are the costs to treat a 
subarachnoid hemorrhage? What are the costs of treating an unruptured aneurysm either 
neurosurgically or via an endovascular approach to avoid SAH with possibly fatal 
complications? Rising costs of treating an aneurysmal hemorrhage have to be weighted 
against the risk of rupture of an incidentally detected aneurysm (65, 146) 
 
2.4.4 Different modalities of aneurysm treatment: 
Medical therapy is usually only an option for the treatment of unruptured intracranial 
aneurysms. Strategies include smoking cessation and blood pressure control; the only 
factors that have been shown to have a significant effect on aneurysm formation, growth, 
and/or rupture. Periodic radiographic imaging (either MRA, CT scan or conventional 
angiography) may be recommended at intervals to monitor the size and/or growth of the 
aneurysm. Because the mechanisms of aneurysm rupture are incompletely understood, and 
because even aneurysms of very small size may rupture, the role of serial imaging for 
cerebral aneurysm is undefined. (11, 33,110) 
Microsurgical clipping is still the preferred treatment modality in most centers due to the 
relatively straight forward surgical approach to most of the aneurysms. In addition to the 
major advantage of surgery which provides effective and durable exclusion of the 
aneurysms, surgery also allows for the management of the increased intracranial pressure 
through evacuation of ICH, the release of cerebrospinal fluid (CSF) and/or hemicraniectomy. 
(11, 36, 48, 110) 
In the last decade after tremendous advances in endovascular techniques and devices, 
several relatively large studies of the endovascular management were published, due to the 
concept that. In spite of the advances, surgical clipping remains an invasive and technically 
challenging procedure. (33) 
2.4.4.1 Endovascular treatment: 
Induce thrombosis of aneurysms by introducing foreign bodies or application of electrical or 
thermic injury through arterial catheterization date back to the first half of the nineteenth 
century. With subsequent improvements in endovascular devices and techniques, led to the 
opening of a new era in the endovascular cerebral aneurysm treatment. (66,86,131,148) Filling 
techniques to induce aneurysm thrombosis and subsequent closure, the “coiling” technique 
represent a “gold standard” in endovascular aneurysm treatment, which has showed much 
progress with development of new coil designs or other endovascular devices like ballon or 
stent to assist embolization. Then the endovascular therapy progressed and replaced the 
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simply filling techniques with materials that promote real endothelialization of the aneurysm 
neck. (47, 91,137) 
Endovascular therapy was restricted to surgical difficult or inaccessible lesions, mostly in the 
posterior circulation, but the increasing experience and development of devices have 
improved the potential, and endovascular therapy has become an alternative to surgical 
treatment. Some limitations are still such as the anatomic situation of the aneurysm, 
aneurysm size or unfavourable or invisible geometry (neck/fundus ratio). The decision to 
treat an aneurysm endovascularly rather than surgically is not easy and requires a 
multidisciplinary input that  requires both the neurosurgeon and the interventionalist to be 
extremely honest about what they think they can achieve with each approach. Neurosurgery 
and interventional neuroradiology are not competitive facilities, but the complementary 
nature of techniques offers the best chance for reducing treatment morbidity and improving 
long-term outcome in difficult aneurysms. (47, 52, 66, 86) 
Flow diverter is among the newest technologies for aneurysm embolization, where only in 
2008 several models were approved in Europe for the treatment of cerebral aneurysms. (68, 
88,145)  The aim of this vascular support is to reconstruct the carrier vessel of the aneurysm. 
This functional principle is based on the one hand on the diversion of the blood flow away 
from the aneurysm, which subsequently leads to the thrombosis, followed by fibrotic 
remodelling, Secondly, the vessel wall is restored by covering the stent at the neck of the 
aneurysm with a neointima consisting of smooth muscle and connective tissue cells.(18,68) 
 
Figure (13) Dendrone electric 
detachable coils different varieties: A, 
standard. B, Cage coil, C, 
Multidiameter coil (Donauer et al., 
2002). 
 
 
Figure (14) Rt, Diagram of 
the Hyperform balloon 
microcatheter, Lt, self-
expanding Neuroform 
microstent (Baldi et al., 
2003). 
 
 
 
 
2.4.4.2 Microsurgical clipping: 
Microsurgical clipping has been used for treating intracranial aneurysms, for more than 40 
years. This procedure involves placing a surgical clip at the junction of the healthy artery and 
the neck of the aneurysm, to ensure the exclusion of the aneurysm from the cerebral 
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circulation, reducing the mass effects on adjacent structures and preserving the parent 
vessel, while eliminating any aneurysmal rests that may subsequently redevelop.  (75, 79) 
The application of microsurgical techniques, have provided a better understanding of the 
aneurysm. The greatest improvements have been in the surgeons’ ability to carry out fine 
manipulations through a tiny gap under high magnification and the availability of precision 
instruments of adequate lengths, parallel to excellent microanatomy orientation through the 
surgical field that can be viewed at great depth, in sharp focus and stereoscopically. Thus, 
with increased experience there has been less need for an alternative method to clipping. 
Nevertheless, there do remain a few cases where clipping is not possible. (4, 81, 125, 154) 
2.4.4.2.1 Strategy for aneurysmal clipping: 
The General strategy an aneurysms surgery is very similar irrespective of the aneurysm 
location or size, with a much less difference between rupture and unuptured aneurysms. 
Giant, partially thrombosed, calcified, and fusiform aneurysms are special subgroups, which 
often need a customized strategy with options for bypassing procedures, endovascular 
balloon occlusions, and intraoperative DSA angiography. Fortunately, these cases represent 
only about 5% of all known aneurysms.  (81,154) 
The actual surgical strategy for treating aneurysms includes the following procedures: 
craniotomy; brain relaxation via releasing CSF and possible partial removal of space 
occupying ICH; establishing proximal and distal control of the parent arteries; aneurysm 
neck dissection under temporary clipping of the arteries; insertion of the pilot clip; further 
dissection of the aneurysm dome from the surrounding structures and possible remodeling 
of the dome; final clipping and checking the patency of the surrounding arteries; removal of 
the remaining ICH if present; application of Surgicel with papaverine locally to prevent 
vasospasm; and wound closure. (81,154) 
In ruptured aneurysms, the greater differences are the more oedematous the brain becomes 
and a constant fear of aneurysm re-ruptures. Thus, in ruptured aneurysms, more time is 
initially spent on obtaining a slack brain and more CSF needs to be released. Unruptured 
aneurysms, in general, are easier to approach than ruptured ones. Aneurysm can be 
approached more freely with only good neuroanesthesia or just releasing CSF from the 
actual cistern where the aneurysm is located. All anatomical structures can be better 
identified and the dissection plane is easier to maintain. A smaller opening of the arachnoid 
is often sufficient and less surrounding structures need to be exposed. (81, 85) 
 
2.4.4.3 Surgical vs Endovascular management:  
For some aneurysms, endovascular treatment may be preferred, whereas for others 
microsurgery is still superior in both cost and outcomes. (17)The choice of open surgery vs. 
endovascular techniques to treat cerebral aneurysms remains an individualized decision. 
Many factors play a role in treatment decision making: age, past medical history, and 
medical/neurological conditions help to determine the patient’s ability to tolerate a specific 
treatment. For example, an old patient with a ruptured aneurysm in poor neurological and 
general condition, coil embolization may be superior to surgery in this setting. On the other 
hand, a young patient with an unruptured aneurysm may be a good candidate for open 
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surgery in anticipation of achieving a durable result. Aneurysm characteristics such as 
location (suitability for surgical access), morphology, and size i.e. MCA aneurysms tend to 
have complex morphologies with wide necks and important arterial branches may be 
incorporated into the aneurysm, these aneurysms tend to be more suitable for open surgery. 
Also, a ruptured aneurysm with a large intracerebral hematoma and mass effect may be 
better suited for surgery. Patient preference also plays a role in which treatment is chosen in 
some instances. Operator preferences are often understated but equally important, this 
includes the operator’s bias toward a certain treatment because of experience and 
familiarity. Some complex aneurysms may require a combination of open and endovascular 
surgeries. (86,158) 
The International subarachnoid aneurysms trial (ISAT), a randomized, multicenter study that 
compared clinical outcomes of patients presenting with ruptured aneurysms, whose treated 
either by clipping or by coiling. Initial clinical outcomes from ISAT indicated little difference 
between endovascular and surgical treatment. However, outcome results at 1 year follow up 
were convincing enough to lead to an early termination of the study, because those treated 
with endovascular coiling had a 6.9% absolute risk reduction and 22% relative risk reduction 
in poor outcome compared with surgical clipping. (86) 
The microsurgical clipping procedure was significantly superior regarding the occlusion of 
ruptured aneurysms. Initial subtotal occlusion is stated in 1.6% of the microsurgical cases 
versus 19.1% of the endovascular cases, in ISAT the complete occlusion rate in the 
endovascular group (discharge until over 2 years) was 66% of the treated aneurysms. 
Retreatment was performed on 17.4% of the patients who underwent endovascular therapy 
and in 3.8% of patients who underwent surgical clipping. Long term follow ups indicated 
endovascular coiling had a higher risk of rebleeding than clipping (6.1% versus 0.4%), but 
the risk was low and remained similar to risk of SAH from another aneurysm. (17, 86,158)  
Van Rooij et al noticed that, the significantly lower absolute rate of symptomatic ischemic 
stroke is (endovascular treatment 19.7% versus microsurgical clipping 5.3%). Also, the 
safety and efficacy profile of flow diversion should discourage the use of these devices in 
aneurysms that can be treated with other techniques. Direct mortality was not significantly 
different between the two groups (endovascular group: 0.9%microsurgical clipping group: 
0.7%). (86,158)      
Although the ISAT study indicated that endovascular treatment was a safe and effective 
alternative to surgical treatment for certain ruptured aneurysms, the results were not 
sufficient to determine that endovascular treatment is superior to surgical treatment in all 
patients with ruptured aneurysms and cannot be applied to unruptured aneurysms. (86) 
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Figure (15) Dissection 
strategy for pcom aneurysm; 
Michael T 2011 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
                    Figure (16) Different technique for microsurgical clipping; Michael T 2011 
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 2.4.5 Screening for Intracranial Aneurysms: 
Of the whole population, about 2% harbor cerebral aneurysms. In most of cases, the 
aneurysm is not prone to rupture and usually remains asymptomatic throughout their life. 
Given the serious consequences of intracranial aneurysmal rupture with catastrophic 
consequences, with up to a 50% mortality rate even with the best available management 
and the emergence of new technologies that can aid diagnosis and treatment before rupture, 
more attention to screening unruptured cerebral aneurysms is mandatory. (16) 
Screening asymptomatic without risk factors or even those with acquired risk factors, such 
as smoking or alcohol abuse do not seem to provide any benefits.(10) Screening the entire 
population for IAs is not logical, since most of them do not harbors IAs. Furthermore, treating 
all diagnosed IAs is unnecessary since most of them will never harm the patients, parallel to 
the cost, time, and potential hazards of screening tools. On the contrary, waiting till IAs 
rupture is not justifiable, as that leaves most patients dead or disabled. (16)  
Screening IAs in patients with positive family history of ruptured intracranial aneurysm is 
controversial. For patients with one affected first-degree relative, the Stroke Council of the 
American Heart Association does not recommend screening aneurysms. (142)   Screening 
patients with positive two or more family members with intracranial aneurysms is more 
complexed. Several studies (16, 78) advocate screening for such patient population, based on 
the higher rupture rates. But more recent studies indicate that screening does not have a 
significant reduction of the morbidity or mortality rates for those patients. Therefore, the 
decision of whether or not to screen is best decided on a case-by-case basis. (20) 
This conflict leads to a major clinical dilemma that should be resolved in future research 
when more is learned about the risk of IAs rupture and the techniques for diagnosis and 
management of intracranial aneurysms are improved. Screening should also be considered 
for patients with rare conditions (e.g. autosomal dominant polycystic kidney disease) that are 
associated with an increased risk of aneurysms. However, it should be based on their overall 
health. In patients with a history of aneurysmal subarachnoid hemorrhage, the annual rate of 
new aneurysm formation is between 1 and 2 percent, and the risk of aneurysmal rupture 
appears to be increased. (37) Therefore, surveillance of these patients with magnetic 
resonance angiography or intra-arterial digital subtraction angiography may be justified. (20) 
2.4.6 Outcome of cerebral aneurysms treatment: 
Meta-analysis of multicenter randomized studies includes ISAT that compares the outcomes 
of ruptured cerebral aneurysms treated either via microsurgical clipping or by endovascular 
therapy, illustrates that the Initial clinical outcomes indicate little differences between 
endovascular and surgical treatment for aneurysms of the anterior circulation but that coiling 
results yield better outcomes for those of the posterior circulation. The effect on mortality 
rates is not statistically different across the two treatments. Rebleeding rates within the first 
month were higher in patients allocated to endovascular coil embolization. (77, 86)  
Regarding the occlusion of ruptured aneurysms, microsurgical clipping procedure is 
significantly superior. Initial subtotal obliteration is stated in 1.6% of the microsurgical cases 
versus 19.1% of the endovascular cases. In ISAT, the complete occlusion rate in the 
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endovascular group (discharge until over 2 years) was 66% of the treated aneurysms. 
Retreatment was performed on 17.4% of the patients who underwent endovascular therapy 
and on 3.8% of the patients who underwent surgical clipping. Long term follow ups indicated 
that endovascular coiling had a higher risk of rebleeding than clipping (6.1% versus 0.4%), 
but the risk was low and remained similar to the risk of SAH from another aneurysm. (17, 
86,154)   
For unruptured cerebral aneurysms, endovascular coiling and surgical clipping have similar 
risk ratios of mortality, bleeding, cerebral ischemia, independence in daily activities, and 
further investigation is needed on quality of life and cognitive outcome. Despite the major 
advances in endovascular techniques, it still bears a lower rate of occlusion and 
microsurgical clipping is still the most efficient procedure. (116,148) 
Long term rupture rates for unruptured aneurysms in patients without a history of  SAH and 
aneurysms located in the internal carotid artery, Acom or ACA, or MCA were 0%, 2·6%, 
14·5%, and 40% for aneurysms less than 7 mm, 7–12 mm, 13–24 mm, and 25 mm or 
greater, respectively, compared with rates of 2·5%, 14·5%, 18·4%, and 50%, respectively, 
for the same-size categories involving posterior circulation and Pcom aneurysms. These 
rates often equal or exceed the risks associated with surgical or endovascular repair of 
comparable lesions. Patients’ age is a strong predictor of surgical outcomes, and the size 
and location of an aneurysm predict both surgical and endovascular outcomes. (116,154)  
The most durable treatment modality for aneurysm is that which could exclude it completely 
from circulation, but the complete microsurgical closure of an aneurysm cannot be achieved 
in all cases, and thus the reported rate of clip remnants varies from 1.6% to 42%. (3, 60,104,121) 
The presence of a clip remnant on postoperative angiography may have far-reaching clinical 
consequences, with a risk of rebleeding in 1.9% of cases and a regrowth risk of 1.83% per 
year. (27,132) Evolution of potentially safer and less invasive endovascular therapies is also 
associated with the risk of aneurysm recurrence or recanalization, and varies over a wide 
range from 17% to 60%. Consequently, follow-up imaging after coil embolization is routinely 
performed to identify recurrent aneurysms before they rupture. (105) 
Many scores have been used as outcome measures of intracranial aneurysms treatment for 
decades: the Glasgow Outcome Scale (GOS), Karnofsky Performance Scale (KPS), the 
modified Rankin scale (mRS), and Functional Status Examination (FSE). All these scores 
are valuable instruments for assessing the patient recovery after aneurysms treatment and 
the impact of SAH. (63, 70, 71,103)   However, not all of them evaluate the efficacy of treatment 
and the variety of the scales which make it impossible to compare the results of different 
studies. (61) 
The frequency and variability of recurrence rates vary widely around the world. Also, human 
decision-making under conditions of uncertainty is a complex, poorly-understood process (99) 
especially when it comes to tremendous responsibility for those who make decisions that 
impact the lives of others and potentially life-long consequences for individuals as those 
decisions made within a doctor–patient  and doctor-doctor relationship,  which is particularly 
true in the management of cerebral aneurysms.(73) Such a matter  requires comprehensive 
and accessible information on treatment efficacy and raises an urgent need for high quality 
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evidence and stratification scale to clearly evaluate the safety and efficacy of these 
techniques, in order to determine which treatment provides the best quality and outcomes 
for patients. 
Score Description 
1 Death  
2 Persistent vegetative state 
Patient exhibits no obvious cortical function. 
3 Severe disability 
Conscious but disabled. Patient depends on others for daily support. 
4 Moderate disability 
Disabled but independent. Patient is independent as far as daily life. Disabilities 
include varying degrees of dysphasia,hemiparesis,or ataxia as well as intellectual and 
memory deficits and personality changes 
5 Good recovery 
Resumption of normal activities even though there may be minor neurologic or 
psychological deficits. 
                            Table (2) Glasgow outcome score, Kim DH 2005    
                                   
Score  Description 
0 No symptoms at all 
1 No significant disability despite symptoms; able to carry all usual duties and 
activities. 
2 Slight disability; unable to carry out all previous activities, but able to look after 
own affairs without assistance 
3 Moderate disability; requiring some help, but able to walk without assistance 
4 Moderately severe disability; unable to walk without assistance and unable to 
attend to own bodily needs without assistance 
5 Severe disability; bedridden, incontinent and requiring constant nursing care 
and attention 
6 Dead 
                                             Table (3) Modified Rankin scale, Kim DH 2005    
 
2.5 Summary and trends for the future: 
From the overview on the review of the literature, it can be concluded that: 
• In the past decade a lot of progress has been achieved to improve the modalities and 
techniques to treat cerebral aneurysms; microsurgical clipping become more efficient, 
less invasive and direct toward eliminating cerebral aneurysms with minimal trauma 
to the brain, normal vessels and surrounding tissues through improved orientation 
and understanding the brain microanatomy, advance in microscope and 
microinstruments parallel to improved handling under high power of magnification 
through tiny gabs, at the same time, progress in endovascular techniques become 
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more complexed from just coil packing to use of ballon or stent and flow diverters with 
the thromboembolic risk and still carry a low aneurysm occlusion rate. 
• The exact mechanism for cerebral aneurysms formation is still unclear, the role of 
inflammatory and genetics process should be extensively examined. So, it might be 
possible to develop pharmaceutical therapies that would reverse the process of IA 
formation 
• When aneurysm is formed, some aneurysms rupture while others do not. Many 
studies have focused on the morphological characteristics of aneurysms on 3D 
angiography to predict rupture risks. Other researches correlate some morphological 
characteristics with the histology of the aneurysms wall in order to determine more 
reliable indicators for the degree of resilience of the aneurysm wall to rupture. All 
available data, however, is suggestive rather than conclusive. Integration of both, 
meticulous examination of the aneurysm tissue provided during microsurgical clipping 
by histochemical and immunological studies and the newly developed investigation 
tools such as the ultra-high-field MRI, that would probably enable examination of the 
aneurysm wall for weak spots, would allow for more reliability when classifying IAs as 
either stable or rupture-risk harboring. 
• Prevention of rebleeding after SAH is a big challenge. Also, the efficacy of 
antifibrinolytic therapy such as aminocaproic acid and tranexamic acid to prevent 
rebleeding and the benefit of statin to control the growth of the aneurysm is still 
conflicting. 
• Issues like the pathogenesis of vasospasm due to SAH and why vasospasm and 
delayed cerebral ischemia occur in rupture aneurysm SAH and rarely occur in 
patients with SAH after rupture of an AVM or perimesencephalic SAH, have not been 
entirely elucidated. 
• Screening for cerebral aneurysm represents a clinical dilemma, as only about 2% of 
the whole population is expected to harbor IAs. In most cases, however, it will not 
rupture or harm the patient. Also, it is an expensive and time-consuming procedure 
that bears the hazards of radiation exposure. Despite that, waiting till an aneurysm 
rupture occurs is not justifiable, as it consequences can be catastrophic. Identifying 
the genetic factors associated with IAs could make screening for them as fast and as 
smooth as a simple blood test, resulting in a higher percentage of patients with IAs 
being identified early. Until that happens; a low threshold to investigate patients with 
any CNS symptoms should be adopted. 
• Preventive medicine is the best route. Despite that, there is no solid indication to treat 
unrupture cerebral aneurysm due to missing real rupture risk. 
• All scores are routinely used to evaluate outcomes after cerebral aneurysms 
treatments, and only measure recovery after any brain insult, irrespective to the 
efficacy of the treatment modality in eliminating the absolute and relative risk of 
aneurysm ruptures. So an urgent need arises for high quality evidence and 
stratification scale to clearly evaluate the safety and efficacy of these techniques and 
to determine which treatment provides the best quality and outcomes for patients. 
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• Advances in endovascular technology might provide for the development of new 
polymer-coated stents and flow diverters which do not require cotreatment with 
antiplatelet drugs. Furthermore, it is not impossible that some of today’s science 
fiction might come true resulting in scientific breakthroughs in the future, whereby we 
witness Nano robots navigating throughout our cerebral arteries to treat IAs or 
strengthen their walls. 
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3. Material and methods: 
3.1 Publication I: Outcome of cerebral aneurysms treatment; new scoring system. 
3.1.1 What is the best score that can be used to evaluate the outcome of intracranial 
aneurysms treatment? Is it the Glasgow outcome score (GOS), the modified Rankin score 
(mRS), Karnofsky performance scale (KPS), functional status examination (FSE) or 
something else? All these scores have been validated for evaluating the patient outcome 
and recovery from any brain insult i.e. stroke, head trauma, tumor, etc.  Although, they are 
also applied to evaluate outcomes for patients after cerebral aneurysms treatment, 
unfortunately, they are not viable to evaluate the efficacy of treatment in eliminating 
aneurysms from the circulation and subsequently eliminating the risk of aneurysm ruptures, 
which is the main aim of treatment. 
Up till now, no available score is specified to evaluate the outcome of cerebral aneurysms 
treatment, as the optimal score should evaluate both the patient outcome (safety of the 
procedure) and the efficacy of treatment parallel to each other. Dissociation between the 
patient outcome and the degree of aneurysm closure, during the discussion of cerebral 
aneurysms treatment results, leads to a lot of conflicts and inconvenience. Therefore, the 
author has created a new score specified to evaluate both the safety and efficacy of the 
cerebral aneurysms treatment. 
3.1.2 Nomenclature: 
BRS score indicates the first letter of the author’s and his mentors' first names, where B 
stands for the author Bahaa Ghareeb Hassanin, R stands for the Egyptian mentor Professor 
Roshdy Elkhyat, and BR stands for the German mentor and head of the department 
Professor Alexander Brawanski and S stands for the cerebrovascular mentor Professor Karl 
Michael Schebesch.  
3.1.3 Description of the scoring system: 
The main risk of harbouring intracranial aneurysms is the risk of rupture with subsequent 
SAH. The goal of any treatment is to exclude the aneurysm from cerebral circulation to 
prevent its rupture. The most efficient treatment modality is that which eliminates the risk of 
rupture with the best patient outcome. The proposed scoring system is based on these two 
parameters: efficacy of treatment and patient outcome. These factors were determined 
based on the follow-up angiography and/or 3DCT, Glasgow Come Score (GCS) and 
neurological examination of the patient. 
BRS Score: 
  -Efficacy of the treatment: 
Based on 3D rotational follow up angiography/ or 3D CT, the efficacy of treatment was 
determined to be: (Table 4) 
A: Complete elimination of the aneurysm. 
B: Small residual at the aneurysm neck less than 3mm. 
C: Residual bleb3mm or more at the aneurysm neck, or shows regrowth on follow up, or 
required retreatment. 
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Table (4) BRS Score 
score  Description 
A Complete elimination of the aneurysm from the circulation. 
B Small residual at the base less than 3mm. 
C Residual 3mm or more or show growth on follow up or required retreatment. 
 
   -Patient outcome: 
Based on the patient Glasgow come score (GCS) and neurological examination, either 
positive (+) or negative (-) charges are added to the above efficacy category. 
Positive charge (+): indicates patient with GCS 15, with no neurological deficit. 
Negative charge (-): indicates patient with impaired levels of consciousness and/or with 
neurological deficits. 
So the full score will be as follow: Table (5) 
Score Description Numerical 
score 
A+ GCS15, No neurological deficit, complete aneurysm elimination from the 
circulation. 
7 
A- DCL and/or Neurological deficit, complete aneurysm elimination from the 
circulation. 
4 
B+ GCS15, No neurological deficit, small residual at the base less than 3mm. 6 
B- DCL and/or Neurological deficit, small residual at the base less than 3mm. 3 
C+ GCS15, No neurological deficit, residual 3mm or more /or show growth on 
follow up /or required retreatment.  
5 
C- DCL and/or Neurological deficit, residual 3mm or more /or show growth on 
follow up /or required retreatment. 
2 
 
Interpretation of the score: Table (6) 
Score  Numerical 
equivalent  
Indication 
A+ 7 Excellent efficacy with good patient outcome. 
B+ 6 Fair efficacy with good patient outcome. 
C+ 5 Inefficient with good patient outcome. 
A- 4 Excellent efficacy with patient impairment. 
B- 3 Fair efficacy with patient impairment. 
C- 2 Inefficient with patient impairment. 
D 1 Death. 
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                            GCS 15, no neurological deficit                impaired conscious level and/or  
                                                                                                 neurological deficit 
 
 
 
 
 
 
 
 
                               Complete aneurysm closure     residual less than 3mm          residual 3mm or more                       Death 
                                                                                                                               Or required retreatment 
 
3.2 Publication II: The extended BRS (exBRS) score to evaluate the outcome of 
cerebral aneurysms treatment. 
3.2.1 Objective:  
The first score specified to evaluate the outcome after cerebral aneurysms treatment, the 
BRS score, previously published by the author, has a limited value as a measure for the 
description of neurological impairment especially in neurologically impaired patients as those 
after SAH insult, which is confusing when it comes to classifying patient outcome and 
recovery after brain insult in patients with rupture aneurysms. Therefore, the authors has 
created a new more extended score to evaluate the efficacy of the treatment modalities 
parallel to a more specific, standardized and objective description of the degree of patient 
recovery and outcome. 
3.2.2 Nomenclature: 
Extended BRS score as it is based on the previous BRS score published by the author but 
with a more extended measure to the neurological state and patient recovery.  
3.2.3 Description of the scoring system: 
The proposed scoring system is based on two parameters: efficacy of treatment and patient 
outcome; the efficacy of the treatment is measured by the degree of aneurysm elimination 
from the circulation based on the follow-up angiography. Patient outcome and recovery are 
based on consciousness level and neurological examination of the patient 
 
Patient outcome 
Good 
+ 
Poor 
- 
A B C D 
Efficacy of the treatment 
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Extended BRS Score: (Table 7) 
• Patient outcome: 
According to the patient GCS and the neurological examination, the patient can be stratified 
into the following category in descending order of the best outcome; 
Grade (5); Competent patient; with the best outcome, with GCS15 and without neurological 
deficit. 
Grade(4); independent patient with GCS15 and mild neurological deficit, which do not 
interfere with the patient’s daily activities, and these include memory impairment, 
aphasia/dysphasia, sensory impairment, cranial nerve affection, and motor affection of one 
limb up to hemiparesis grade 4/5. 
Grade (3); Dependent patient; with moderate to severe neurological affection that required 
assistance in accomplishing the daily activity. These include impaired level of conscious 
and/or motor affection hemiparesis grade 3/5 or more. 
Grade(2); Vegetative patient; absence of responsiveness and awareness due to 
overwhelming dysfunction of the cerebral hemispheres, with sufficient sparing of the 
diencephalon and brain stem to preserve autonomic and motor reflexes and sleep-wake 
cycles. 
Grade (1);    Death 
Extended BRS Score: Table (7) 
Score  Finding Description  
5 GCS15, No neurological deficit. Competent. 
4 GCS15 with mild neurological impairment which include; memory 
impairment, aphasia/dysphasia, sensory impairment, cranial nerve 
affection one limb motor affection up to hemiparesis G4/5. 
Independent. 
(Mild impairment) 
3 Impaired level of conscious and/or motor affection more than one 
limb; hemiparesis G 3/5 or more. 
Dependent.  
(moderate to severe 
impairment) 
2 absence of responsiveness and awareness due to overwhelming 
dysfunction of the cerebral hemispheres, with sufficient sparing of the 
diencephalon and brain stem to preserve autonomic and motor 
reflexes and sleep-wake cycles 
Vegetative.  
1 Death.  Death. 
• Efficacy of the treatment: 
For each of the above categories from grade 5 to grade 2, either A, B or C will be added; 
• A:  this indicates complete aneurysm elimination from the circulation. 
• B: this indicates small residual at the aneurysm neck less than 3mm. 
• C: this indicates residual 3mm or more, or shows regrowth on follow up or 
required retreatment. 
So the final score will be; Table (8); 
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Score  Finding Numerical 
equivalent 
5A Competent, complete elimination of the aneurysm from the circulation. 13 
5B Competent, small residual at the aneurysm base less than 3mm. 12 
5C Competent, residual 3 mm or more or growth on follow up or retreatment 11 
4A Independent, complete elimination of the aneurysm from the circulation. 10 
4B Independent, small residual at the aneurysm base less than 3mm. 9 
4C Independent, residual 3 mm or more or growth on follow up or 
retreatment. 
8 
3A Dependent, complete elimination of the aneurysm from the circulation. 7 
3B Dependent, small residual at the aneurysm base less than 3mm. 6 
3C Dependent, residual 3 mm or more or growth on follow up or retreatment. 5 
2A Vegetative, complete elimination of the aneurysm from the circulation. 4 
2B Vegetative, small residual at the aneurysm base less than 3mm. 3 
2C Vegetative, residual 3 mm or more or growth on follow up or retreatment. 2 
1 Death.  1 
 
 
 
     5 
 
 
 
                                                                  4                                      Complete aneurysm closure 
 
      
  
 3 
 
                                                                                                          Residual less than 3mm 
 
      
 
  2 
 
 
                                                                                                              Residual 3mm or more or                  
1 required retreatment 
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Outcome 
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Dependent 
Vegetative 
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of 
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t 
A 
B 
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 3.3 Assessment of the new scores: 
1) The accuracy and predictive value of the new score to the patient outcome and 
efficacy of treatment, in comparison with the commonly used scores, was studied 
using the Receiver operating characteristic (ROC) curve.  
2) To evaluate the significance and reliability of the new score, it was retrospectively 
applied on a sample of patients with intracranial aneurysms divided into ruptured and 
unruptured groups, that were treated either via microsurgical clipping or endovascular 
intervention at Regensburg university hospital and the illustrated results were highly 
comparable to the high-quality internationally published ones.  
 
  3.4 Data analysis: 
Data was analysed using IBM SPSS Statistics for Windows version 20.0 and Medcalc 
version 18.6.  Quantitative data is expressed as means ± standard deviation, median, and 
range.  Qualitative data is expressed as numbers and percentages. Chi-square (χ2) test was 
used for comparison of qualitative variables. Receiver operating characteristic (ROC) curve 
was constructed for the studied old and new scores, in predicting the outcome and efficacy 
of intracranial aneurysms, and the area under the ROC curve value with 95% CI was 
calculated. A 5% level was chosen as a level of significance in all statistical tests used in the 
study. 
 
4.  Results: 
4.1 statistical analyses of the validity and predictive value of the new scores in 
comparison with traditional scores by ROC reveal the following: 
- High specifity and sensitivity of the new scores to evaluate the efficacy of the 
treatment modalities with AUC are so close to 1.0 and high significant p-value. In 
comparison with the traditionally-used score which was not significant at all.  
- The new scores are significant as well as the traditional scores used to evaluate 
patient outcome but BRS score is not expressive for the severity of neurological 
impairment especially for rupture aneurysms group. The ex BRS score is highly 
significant as well as the traditional scores to evaluate the patient outcome and 
differentiate it into different degree of neurological impairment. 
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Table (9): Receiver operating characteristic (ROC) curve of old and new scores in predicting efficacy of treatment 
 
Score  Cutoff AUC 95% CI Sensitivity Specificity P-value 
Complete aneurysm closure  
GOS ≤ 4 0.507 0.429 - 0.585 1.47 100 0.896 
Modified Rankin score >1 0.507 0.429- 0.585 1.47 100 0.896 
BRS Score >6 0.982 0.949 - 0.996 97.79 100 <0.001* 
Extended BRS Score >12 0.982 0.949 - 0.996 97.79 100 <0.001* 
Residual less than 3mm  
GOS > 4 0.507 0.429 - 0.585 100 1.43 0.904 
Modified Rankin score ≤ 1 0.507 0.429- 0.585 100 1.43 0.904 
BRS Score ≤ 6 0.96 0.918- 0.984 100 95 <0.001* 
Extended BRS Score ≤ 12 0.96 0.918- 0.984 100 95 <0.001* 
Residual 3mm or more  
GOS > 4 0.506 0.428 - 0.584 100 1.23 0.962 
Modified Rankin score ≤1 0.506 0.428 - 0.584 100 1.23 0.962 
BRS Score ≤ 6 0.941 0.894 - 0.972 100 81.6 <0.001* 
Extended BRS Score ≤ 12 0.941 0.894 - 0.972 100 81.6 <0.001* 
The need for retreatment  
GOS > 4 0.506 0.428 - 0.584 100 1.23 0.962 
Modified Rankin score ≤1 0.506 0.428 - 0.584 100 1.23 0.962 
BRS Score ≤ 5 0.982 0.948 - 0.996 100 97.55 <0.001* 
Extended BRS Score ≤ 11 0.982 0.948 - 0.996 100 97.55 <0.001* 
* Statistically significant 
Figure (17): Receiver operating characteristic (ROC) curve of old and new scores in predicting complete aneurysm 
closure  
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Figure (18): Receiver operating characteristic (ROC) curve of old and new scores in predicting residual less than 3mm  
 
 
 
 
 
 
 
 
 
 Figure (19): Receiver operating characteristic (ROC) curve of old and new scores in predicting residual 3mm or more  
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Figure (20): Receiver operating characteristic (ROC) curve of old and new scores in predicting retreatment  
 
       Table (10): Receiver operating characteristic (ROC) curve of old and new scores in predicting outcome  
 
Score  Cutoff AUC 95% CI Sensitivity Specificity P-value 
Neurological deficit  
GOS ≤ 4 1 0.978 to 1 100 100 <0.001* 
Modified Rankin score >1 1 0.978 to 1 100 100 <0.001* 
BRS score ≤ 4 1 0.978 to 1 100 100 <0.001* 
Extended BRS score ≤ 10 1 0.978 to 1 100 100 <0.001* 
      * Statistically significant 
 
Figure (21): Receiver operating characteristic (ROC) curve of old and new scores in predicting neurological deficit 
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4.2 To assess the reliability and significance of the new scores, the scores are 
retrospectively applied to a 532 patients harbouring 622 intracranial aneurysms (62 patients 
have multiple aneurysm; all are asymptomatic unruptured aneurysm, only 6 patient have 
unruptured aneurysm incidentally discovered with ruptured one); 313 aneurysms were 
unruptured and 309 aneurysms were ruptured; in the ruptured group, 130 aneurysms treated 
with microsurgical clipping and 179 aneurysms treated with interventional endovascular 
techniques. For the unrupturd aneurysms group, 168 aneurysms treated with microsurgical 
clipping and 145 aneurysms treated with interventional endovascular techniques and the 
traditional results are as follows: 
 
Table (11): Distribution of the studied patients by gender, age, family history and treatment group (No.=622). 
 
Characteristics  Summary statistics 
Gender  
Male  
Female  
 
196 (31.5%) 
426 (68.5%) 
Age(years) 
Mean± S.D. 
Median (Range) 
 
53.9 ± 11.58 
53 (9 - 86) 
Positive family history   
No 
Yes  
 
611 (98.2%) 
11 (1.8%) 
Treatment groups 
Clipping ruptured  
Clipping unruptured  
Coiling ruptured  
Coiling unruptured  
 
130 (20.9%) 
168 (27%) 
179 (28.8%) 
145 (23.3%) 
 
                          Figure (22): Distribution of the studied patients by treatment group (No=622). 
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                    Table (12): comparison between the four treatment groups regarding outcome and efficacy 
 
Parameter   clipping ruptured 
(N=130) 
clipping 
unruptured  
(N=168) 
coiling 
ruptured 
(N=179) 
Coiling  
unruptured 
(N=145) 
P-value 
No residual in Follow up  
No 
Yes    
 
11 (8.5%) 
119 (91.5%) 
 
32 (19%) 
136 (81%) 
 
68 (38%) 
111 (62%) 
 
50 (34.5%) 
95 (65.5%) 
 
<0.001
* 
Residual less than 3mm 
No 
Yes    
 
122 (93.8%) 
8 (6.2%) 
 
140 (83.3%) 
28 (16.7%) 
 
115 (64.2%) 
64 (35.8%) 
 
101 (69.7%) 
44 (30.3%) 
 
<0.001
* 
Residual 3mm or more 
No 
Yes    
 
127 (97.7%) 
3 (2.3%) 
 
163 (97%) 
5 (3%) 
 
175 (97.8%) 
4 (2.2%) 
 
139 (95.9%) 
6 (4.1%) 
 
0.744 
Retreatment   
No 
Yes    
 
126 (96.9%) 
4 (3.1%) 
 
163 (97%) 
5 (3%) 
 
157 (87.7%) 
22 (12.3%) 
 
120 (82.8%) 
25 (17.2%) 
 
<0.001
* 
Post-operative GCS 15  
No 
Yes    
 
30 (23.1%) 
100 (76.9%) 
 
0 (0.0%) 
168 (100%) 
 
45 (25.1%) 
134 (74.9%) 
 
0 (0.0%) 
145 (100%) 
 
<0.001
* 
Post-operative GCS 12-14   
No 
Yes    
 
124 (95.4%) 
6 (4.6%) 
 
168 (100%) 
0 (0.0%) 
 
173 (96.6%) 
6 (3.4%) 
 
145 (100%) 
0 (0.0%) 
 
0.005* 
Post-operative vegetative   
No 
Yes    
 
124 (95.4%) 
6 (4.6%) 
 
168 (100%) 
0 (0.0%) 
 
177 (98.9%) 
2 (1.1%) 
 
145 (100%) 
0 (0.0%) 
 
0.001* 
Death  
No 
Yes    
 
113(86.9%) 
17 (13.1%) 
 
168 (100%) 
0 (0.0%) 
 
143 (79.9%) 
36 (20.1%) 
 
145 (100%) 
0 (0.0%) 
 
<0.001
* 
Post-operative Neurological 
deficit  
No 
Yes    
 
 
107 (82.3%) 
23 (17.7%) 
 
 
166 (98.8%) 
2 (1.2%) 
 
 
152 (84.9%) 
27 (15.1%) 
 
 
141 (97.2%) 
4 (2.8%) 
 
<0.001
* 
 P- Value was calculated by Chi Squa 
* Statistically significant 
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                    Table (13): Distribution of the studied patients by old and new scores (No=622). 
 
Characteristics  Summary statistics 
GOS  
1 
2 
3 
4 
5  
 
55 (8.8 %) 
10 (1.6%) 
33 (5.3 %) 
28 (4.5%) 
496 (79.8%) 
Modified Rankin score  
1 
2 
3 
4 
5 
6   
 
497 (79.9%) 
17 (2.7%) 
34 (5.5 %) 
11 (1.8%) 
9 (1.4%) 
54 (8.7%) 
New score  
A- 
A+ 
B- 
B+ 
C- 
C+ 
D   
 
47 (7.6 %) 
359 (57.7%) 
19 (3.1 %) 
83 (13.3 %) 
3 (0.5%) 
56 (9%) 
55 (8.8 %) 
New score  
1 
2C 
2A 
3B 
3A 
4C 
4B 
4A 
5C 
5B 
5A 
 
55 (8.8 %) 
1 (0.2%) 
7 (1.1%) 
7 (1.1%) 
27 (4.3%) 
3 (0.5%) 
9 (1.4%) 
15 (2.4%) 
56 (9%) 
83 (13.3%) 
359 (57.7%) 
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                 Table (14): comparison between the four treatment groups regarding old and new scores 
 
Score  clipping 
ruptured 
(N=130) 
clipping 
unruptured  
(N=168) 
coiling 
ruptured 
(N=179) 
Coiling  
unruptured 
(N=145) 
P-value 
GOS  
1 
2 
3 
4 
5   
 
18 (13.8%) 
7 (5.4%) 
19 (14.6%) 
6 (4.6%) 
80 (61.5%) 
 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
2 (1.2%) 
166 (98.8%) 
 
37 (20.7%) 
3 (1.7%) 
14 (7.8%) 
14 (7.8%) 
111 (62%) 
 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
6 (4.1%) 
139 (95.9%) 
 
<0.001* 
Modified Rankin score  
1 
2 
3 
4 
5 
6   
 
80 (61.5%) 
3 (2.3%) 
16 (12.3%) 
8 (6.2%) 
6 (4.6%) 
17 (13.1%) 
 
166 (98.8%) 
0 (0.0%) 
2 (1.2%) 
0 (0.0%) 
0 (0.0%) 
   0 (0.0%) 
 
111 (62%) 
10 (5.6%) 
15 (8.4%) 
3 (1.7%) 
3 (1.7%) 
37 (20.7%) 
 
140(96.6%) 
4 (2.8%) 
1 (0.7%) 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
 
<0.001* 
BRS score  
A- 
A+ 
B- 
B+ 
C- 
C+ 
D   
 
29 (22.3%) 
73 (56.2%) 
3 (2.3%) 
3 (2.3%) 
0 (0.0%) 
4 (3.1%) 
18 (13.8%) 
 
2 (1.2%) 
133 (79.2%) 
0 (0.0%) 
26 (15.5%) 
0 (0.0%) 
7 (4.2%) 
0 (0.0%) 
 
15 (8.4%) 
59 (33%) 
13 (7.3%) 
33 (18.4%) 
3 (1.7%) 
19 (10.6%) 
37 (20.7%) 
 
1 (0.7%) 
94 (64.8%) 
3 (2.1%) 
21 (14.5%) 
0 (0.0%) 
26 (17.9%) 
0 (0.0%) 
 
 
<0.001* 
Extended BRS score
  
1 
2C 
2A 
3B 
3A 
4C 
4B 
4A 
5C 
5B 
5A 
 
 
18 (13.8%) 
0 (0.0%) 
6 (4.6%) 
1 (0.8%) 
18 (13.8%) 
0 (0.0%) 
1 (0.8%) 
6 (4.6%) 
4 (3.1%) 
3 (2.3%) 
73 (56.2%) 
 
 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
2 (1.2%) 
7 (4.2%) 
26 (15.5%) 
133 (79.2%) 
 
 
37 (20.7%) 
1 (0.6%) 
1 (0.6%) 
6 (3.4%) 
9 (5%) 
2 (1.1%) 
6 (3.4%) 
6 (3.4%) 
19 (10.6%) 
33 (18.4%) 
59 (33%) 
 
 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
1 (0.7%) 
2 (1.4%) 
1 (0.7%) 
26 (17.9%) 
21 (14.5%) 
94 (64.8%) 
 
 
 
<0.001* 
  P- Value was calculated by Chi Square test 
  * Statistically significant 
 
                                       
 
 
 
 
 
43 
 
                              Figure (23): comparison between the four treatment groups regarding GOS 
 
 
                                                  
 
              Figure (24): comparison between the four treatment groups regarding Modified Rankin score 
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After application of the new score the results are as follows: 
4.3 Outcome with BRS score (Publication I): 
For unruptured aneurysms group: 
According to the new score; 1- good patient outcome was 98.8% (n=166) for clipping group; 
complete aneurysm occlusion "BRS score A+" was 79.2% (n=133), partial aneurysm closure 
with neck remnant less than 3mm "BRS score B+" was 15.5% (n=26) and aneurysm residual 
at the neck 3mm or more or required retreatment "BRS score C+" was 4.2% (n=7). 
compared to endovascular group; good patient outcome was 97.2% (n=141); complete 
aneurysms closure "BRS score A+" was 64.8% (n=94), partial aneurysm closure with neck 
remnant less than 3mm "BRS score B+" was 14.5% (n=21) and neck remnant 3mm or more 
or required retreatment "BRS score C+" was 17.9% (n=26). 
2- patient impairment was 1.2% (n=2) in clipping group, all was complete aneurysm closure 
"BRS score A-".compared to 2.8% (n=4) in endovascular group; 0.7% (n=1) was complete 
aneurysm closure "BRS score A-" and 2.1% (n=3) was partial aneurysms closure with neck 
residual less than 3mm "BRS score B-".  
By the traditionally used score; best outcome; GOS 5 and mRankin 1 was 98.8%, 98.8% 
(n=166) for clipping group and 95.9% (n=139), 96.6% (n=140) for endovascular group 
respectively. Poor patient outcome was; for clipping group 1.2% (n=2) GOS 4 and 1.2% 
(n=2) mRankin scale3. For endovascular group was 4.1% (n=6) GOS 4 and 2.8% (n=4) m 
Rankin scale 4 and .0.7% (n=1) mRankin scale 3.  
 
For rupture aneurysms group:  
By new score: 1- good patient outcome was 61.5% (n=80) for clipping group; complete 
aneurysm closure "BRS score A+" was 56.2% (n=73), partial aneurysm closure with neck 
remnant less than 3mm "BRS score B+" was 2.3% (n=3) and aneurysm residual at the neck 
3mm or more or required retreatment "BRS score C+" was 3.1% (n=4). compared to 
endovascular group; good patient outcome was 62% (n=111); complete aneurysms closure 
"BRS score A+" was 33% (n=59), partial aneurysm closure with neck remnant less than 
3mm "BRS score B+" was 18.4% (n=33) and neck remnant 3mm or more or required 
retreatment "BRS score C+" was 10.6% (n=19). 
2- patient impairment was 24.6% (n=32) in clipping group, complete aneurysm closure BRS 
"score A-" was 22.3% (n=29) and 2.3% (n=3) was partial aneurysms closure with neck 
residual less than 3mm "BRS score B-" .compared to 17.3% (n=31) in endovascular group; 
8.4% (n=15) was complete aneurysm closure "BRS score A-", 7.3% (n=13) was partial 
aneurysms closure with neck residual less than 3mm "BRS score B-" and 1.7% (n=3) neck 
residual 3mm or more or required retreatment "BRS score C-". Mortality "BRS score D" was 
13.8% (n=18) for clipping group and 20.7% (n=37) for endovascular group. 
By the traditionally used score; best outcome; GOS 5 and mRankin 1 was 61.5% (n=80) for 
clipping group and 62% (111) for endovascular group in both scores. Poor patient outcome 
was 24.7% (n=32) for clipping group and 17.3% (n=31) in endovascular group by both 
scores in different degree of neurological impairment. Mortality was 13.8% (n=18) for 
clipping group and 20.7% (n=37) in endovascular group by both scores.     
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                               Figure (25): comparison between the four treatment groups regarding BRS score 
 
 
 
4.4 Outcome with Extended BRS Score (publication II): 
For unruptured aneurysms group: 
According to the new score;  
1- good competent patient outcome was 98.8% (n=166) for clipping group; complete 
aneurysm occlusion "exBRS score 5A" was 79.2% (n=133), partial aneurysm closure with 
neck remnant less than 3mm "exBRS score 5B" was 15.5% (n=26) and aneurysm residual 
at the neck 3mm or more or required retreatment "exBRS score 5C was 4.2% (n=7). 
Compared to endovascular group; good competent patient outcome was 97.2% (n=141); 
complete aneurysms closure "exBRS score 5A" was 64.8% (n=94), partial aneurysm closure 
with neck remnant less than 3mm "exBRS score 5B" was 14.5% (n=21) and neck remnant 
3mm or more or required retreatment "exBRS score 5C" was 17.9% (n=26). 
2- Patient impairment: all was independent patient outcome exBRS score 4 (mild 
neurological impairment). was 1.2% (n=2) in clipping group, all was complete aneurysm 
closure "exBRS score 4A".compared to 2.8% (n=4) in endovascular group; 0.7% (n=1) was 
complete aneurysm closure "exBRS score 4A", 1.4% (n=2) was partial aneurysms closure 
with neck residual less than 3mm "ex BRS score 4B" and neck residual 3mm or more 
"exBRS score 4C" was 0.7% (n=1). 
For rupture aneurysms group: 
By the new score:  
• Microsurgical clipping group;  
1- Good competent patient outcome was 61.6% (n=80) for clipping group; complete 
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aneurysm closure "exBRS score 5A" was 56.2% (n=73), partial aneurysm closure with neck 
remnant less than 3mm "exBRS score 5B" was 2.3% (n=3) and aneurysm residual at the 
neck 3mm or more or required retreatment "exBRS score 5C was 3.1% (n=4).  
2- Patient impairment was 24.6% (n=26) as follows: 
- Independent patient with mild neurological impairment exBRS 4 was 5.4% (n=7); complete 
aneurysm closure "exBRS score 4A" was 4.6% (n=6) and 0.8% (n=1) was partial aneurysms 
closure with neck residual less than 3mm "exBRS score 4B. 
- Dependant patient with moderate to severe neurological impairment exBRS 3 was 14.6% 
(n=19); complete aneurysm closure "exBRS score 3A" was 13.8% (n=18), 0.8% (n=1) was 
partial aneurysms closure with neck residual less than 3mm "exBRS score 3B. 
- Vegetative patient exBRS score 2 was and 4.6% (n=6), all was complete aneurysm closure 
"exBRS 2A".  
-Mortality exBRS score 1 was 13.8% (n=18). 
• Endovascular group: 
1- Good patient outcome was 62% (n=111); complete aneurysms closure "exBRS score 5A" 
was 33% (n=59), partial aneurysm closure with neck remnant less than 3mm "exBRS score 
5B" was 18.4% (n=33) and neck remnant 3mm or more or required retreatment "exBRS 
score 5C was 10.6% (n=19).  
2-poor patient outcome was 17.5% (n=31) as follow;  
-Independent patient with mild neurological impairment 7.9% (n=14); complete aneurysm 
closure "exBRS score 4A was 3.4% (n=6), 3.4% (n=6) was partial aneurysms closure with 
neck residual less than 3mm "exBRS score 4B" and 1.1% "(n=2) neck residual 3mm or more 
or required retreatment "exBRS score 4C".  
-Dependant patient with moderate to severe neurological impairment 8.4% (n=15); complete 
aneurysm closure "exBRS score 3A" was 5% (n=9), 3.4% (n=6) was partial aneurysms 
closure with neck residual less than 3mm "exBRS score 3B". 
-Vegetative patient was 1.2% (n=2); complete aneurysm closure "exBRS score 2A" was 
0.6% (n=1), 0.6% (n=1) was neck residual 3mm or more or required retreatment "exBRS 
2C".  
-Mortality exBRS score 1 was 20.7% (N=37). 
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                        Figure (26): comparison between the four treatment groups regarding Extended BRS score 
 
 
                                  
 
5. Discussion: 
The selection of 3mm as the cut parameter between the second and third grade of efficacy 
is based on 26 studies, describing the growth rate of aneurysms 3 mm and smaller, 5 mm 
and smaller, and 7 mm and smaller, respectively, whereas rupture rates were reported in 7, 
11, and 13 studies for aneurysms 3 mm and smaller, 5 mm and smaller, and 7 mm and 
smaller, respectively. The annualized growth rate was less than 3% in all. The annualized 
rupture rate was 0%, less than 0.5%, and less than 1% for the 3 size categories, 
respectively. (3, 4) 
The studied group for which the score was applied, has a results in line with the international 
published studies i.e. ISUIA, ISAT, either in the patient outcome, rate of occlusion and the 
need for retreatment; so the score is highly specific and illustrative to summarized all aspect 
of aneurysm treatment in a sharp numerical score.  
Significance of the new scores: 
• Combine the neurological performance and the radiographically confirmed occlusion. 
The new BRS score is an easy applicable score to predict precisely the outcome after 
aneurysm treatment.  
• This score can be applied to patients as early as the discharge date with the base 
line follow up angiography, also can follow the course of treatment once it is  applied 
on each follow up at 6 months, one year…etc. So, not only does it evaluate the 
outcome at once, but also it follows the aneurysm on long term treatment with clear, 
sharp and numerical score. Score improvement or regression will give a significant 
indication about the long term efficacy of treatment, aneurysm regrowth, coil 
compaction, and clip slipping. 
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• With a simple sharp numerical score applied to aneurysms data, many conflicts can 
be easily resolved, i.e. the best treatment for each aneurysm location, and to decide 
which group will need to be followed up. So, decreasing the cost and hazard of 
exposure to radiation and any newly developed techniques, in the future, will be 
clearly evaluated, i.e. endovascular, genetic, etc…  
• This score is applicable for patients with single or multiple aneurysms, as it is applied 
to each aneurysm separately, even the conflicting group with multiple aneurysms in 
whom the unruptured aneurysm are incidentally discovered with ruptured ones who 
have recovered with neurological impairment, BRS score will fit them very well 
(where the + charge will represent no recent neurological impairment and – charge 
will represent recent impaired level conscious or neurological deficit).  
Comparing our two new scores; both scores Combine the neurological performance and the 
radiographically confirmed occlusion and are easy applicable scores to predict precisely the 
outcome after aneurysm treatment. BRS score is simpler, but has alimited value to 
differentiate the degree of neurological impairment especially for rupture aneurysms; exBRS 
score has the advantage of more significant ability to classify different degrees of 
neurological impairments from complete neurological intact patients passing through mild, 
moderate and sever neurological impairments.  
Compared with the traditionally used scores such as GOS, and mRankin scale, extended 
BRS score can efficiently measure patient outcome with high index in stratifying the degree 
of neurological impairment, with the advantage of its ability to measure the efficacy of 
treatment modality, an advantage not provided by other scores. 
The patient outcome part of the extended BRS score is based on sharp solid clinical signs 
which aren’t subjected to any bias or interobserver conflict or changes that may occur with 
the commonly used scores. The point that makes the patient outcome part of the extended 
BRS score a golden measurement tool for the patient and brain recovery, not only in 
patients with cerebral aneurysms but for all patients with brain insults. 
Limitation of the study: 
Retrospective application of the scores, dependence on learning curve for the radiologists 
and application of these score to a large sample of patient with cerebral aneurysms is 
recommended. 
6. Conclusion: 
The new scores are the first available score, specified to evaluate outcomes after treatment 
of cerebral aneurysms, combine the neurological performance and the radiographically 
confirmed occlusion. These score are simple, easy applicable, reliable and allow for a 
standardized and objective description of the efficacy of treatment modality and patient 
recovery that can be used to evaluate the current modalities, i.e. microsurgical clipping, 
endovascular intervention or any further modality that may be developed in the future.  
These scores reflect the real image of efficacy in treating cerebral aneurysms without 
confusion. They will play a significant role in resolving many conflicts that arise during the 
discussion concerning cerebral aneurysms treatment.  
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